<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:52:46Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8205178" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8205178</identifier>
        <datestamp>2021-06-29</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" xml:lang="en" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8205178</article-id>
              <article-id pub-id-type="pmcid">PMC8205178</article-id>
              <article-id pub-id-type="pmc-uid">8205178</article-id>
              <article-id pub-id-type="pmid">34129608</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-20-19611</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Viral Diseases</subject>
                        <subj-group>
                          <subject>Covid 19</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and places</subject>
                  <subj-group>
                    <subject>Geographical locations</subject>
                    <subj-group>
                      <subject>Europe</subject>
                      <subj-group>
                        <subject>European Union</subject>
                        <subj-group>
                          <subject>Spain</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Infectious Disease Epidemiology</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Infectious Disease Epidemiology</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Quarantines</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Population Biology</subject>
                    <subj-group>
                      <subject>Population Metrics</subject>
                      <subj-group>
                        <subject>Death Rates</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>RNA viruses</subject>
                        <subj-group>
                          <subject>Coronaviruses</subject>
                          <subj-group>
                            <subject>SARS coronavirus</subject>
                            <subj-group>
                              <subject>SARS CoV 2</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical microbiology</subject>
                      <subj-group>
                        <subject>Microbial pathogens</subject>
                        <subj-group>
                          <subject>Viral pathogens</subject>
                          <subj-group>
                            <subject>Coronaviruses</subject>
                            <subj-group>
                              <subject>SARS coronavirus</subject>
                              <subj-group>
                                <subject>SARS CoV 2</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and health sciences</subject>
                  <subj-group>
                    <subject>Pathology and laboratory medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial pathogens</subject>
                        <subj-group>
                          <subject>Viral pathogens</subject>
                          <subj-group>
                            <subject>Coronaviruses</subject>
                            <subj-group>
                              <subject>SARS coronavirus</subject>
                              <subj-group>
                                <subject>SARS CoV 2</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral pathogens</subject>
                        <subj-group>
                          <subject>Coronaviruses</subject>
                          <subj-group>
                            <subject>SARS coronavirus</subject>
                            <subj-group>
                              <subject>SARS CoV 2</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Vaccination and Immunization</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Vaccination and Immunization</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Public and Occupational Health</subject>
                    <subj-group>
                      <subject>Preventive Medicine</subject>
                      <subj-group>
                        <subject>Vaccination and Immunization</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Mathematical modeling of the transmission of SARS-CoV-2—Evaluating the impact of isolation in São Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of CoViD-19</article-title>
                <alt-title alt-title-type="running-head">CoViD-19 in São Paulo State and Spain</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1711-363X</contrib-id>
                  <name>
                    <surname>Yang</surname>
                    <given-names>Hyun Mo</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8029-6662</contrib-id>
                  <name>
                    <surname>Lombardi Junior</surname>
                    <given-names>Luis Pedro</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Castro</surname>
                    <given-names>Fábio Fernandes Morato</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Validation</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yang</surname>
                    <given-names>Ariana Campos</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Validation</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Applied Mathematics, State University of Campinas, Campinas, São Paulo, Brazil</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Division of Allergy and Immunology, General Hospital of the Medicine School of University of São Paulo, São Paulo, São Paulo, Brazil</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Cheong</surname>
                    <given-names>Siew Ann</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Nanyang Technological University, SINGAPORE</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>hyunyang@ime.unicamp.br</email></corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>15</day>
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>15</day>
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>16</volume>
              <issue>6</issue>
              <elocation-id>e0252271</elocation-id>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>6</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>12</day>
                  <month>5</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 Yang et al</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Yang et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0252271.pdf"/>
              <abstract>
                <p>Coronavirus disease 2019 (CoViD-19), with the fatality rate in elder (60 years old or more) being much higher than young (60 years old or less) patients, was declared a pandemic by the World Health Organization on March 11, 2020. A mathematical model considering young and elder subpopulations under different fatality rates was formulated based on the natural history of CoViD-19 to study the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The model considered susceptible, exposed, asymptomatic, pre-symptomatic, mild CoViD-19, severe CoViD-19, and recovered compartments, besides compartments of isolated individuals and those who were caught by test. This model was applied to study the epidemiological scenario resulting from the adoption of quarantine (isolation or lockdown) in many countries to control the rapid propagation of CoViD-19. We chose as examples the isolation adopted in São Paulo State (Brazil) in the early phase but not at the beginning of the epidemic, and the lockdown implemented in Spain when the number of severe CoViD-19 cases was increasing rapidly. Based on the data collected from São Paulo State and Spain, the model parameters were evaluated, and we obtained a higher estimation for the basic reproduction number <italic toggle="yes">R</italic><sub>0</sub> (9.24 for São Paulo State, and 8 for Spain) compared to the currently accepted estimation of <italic toggle="yes">R</italic><sub>0</sub> around 2 using the SEIR (susceptible, exposed, infectious, and recovered compartments) model. In comparison with the lockdown in Spain, the relatively early adoption of the isolation in São Paulo State resulted in enlarging the period of the first wave of the epidemic and delaying its peak. The model allowed to explain the flattening of the epidemic curves by quarantine when associated with the protective measures (face mask, washing hands with alcohol and gel, and social distancing) adopted by the population. The description of the epidemic under quarantine and protections can be a background to foreseen the epidemiological scenarios from the release strategies, which can help guide public health policies by decision-makers.</p>
              </abstract>
              <funding-group>
                <funding-statement>The author(s) received no specific funding for this work.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="7"/>
                <table-count count="4"/>
                <page-count count="24"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>The data that support the findings of this study are openly available: São Paulo State at <ext-link xlink:href="https://www.saopaulo.sp.gov.br/coronavirus#numero-vacinacao" ext-link-type="uri">https://www.saopaulo.sp.gov.br/coronavirus#numero-vacinacao</ext-link> and <ext-link xlink:href="https://www.seade.gov.br" ext-link-type="uri">https://www.seade.gov.br</ext-link>; and Spain at <ext-link xlink:href="https://cnecovid.isciii.es/covid19/" ext-link-type="uri">https://cnecovid.isciii.es/covid19/</ext-link> and <ext-link xlink:href="https://www.ine.es/en/index.htm" ext-link-type="uri">https://www.ine.es/en/index.htm</ext-link>. Other public database: <ext-link xlink:href="https://www.populationpyramid.net/" ext-link-type="uri">https://www.populationpyramid.net/</ext-link>.</meta-value>
                </custom-meta>
                <custom-meta id="outbreaks">
                  <meta-name>Outbreaks</meta-name>
                  <meta-value>COVID-19</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>The data that support the findings of this study are openly available: São Paulo State at <ext-link xlink:href="https://www.saopaulo.sp.gov.br/coronavirus#numero-vacinacao" ext-link-type="uri">https://www.saopaulo.sp.gov.br/coronavirus#numero-vacinacao</ext-link> and <ext-link xlink:href="https://www.seade.gov.br" ext-link-type="uri">https://www.seade.gov.br</ext-link>; and Spain at <ext-link xlink:href="https://cnecovid.isciii.es/covid19/" ext-link-type="uri">https://cnecovid.isciii.es/covid19/</ext-link> and <ext-link xlink:href="https://www.ine.es/en/index.htm" ext-link-type="uri">https://www.ine.es/en/index.htm</ext-link>. Other public database: <ext-link xlink:href="https://www.populationpyramid.net/" ext-link-type="uri">https://www.populationpyramid.net/</ext-link>.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Coronavirus disease 2019 (CoViD-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a strain of the RNA-based SARS-CoV-1. The SARS-CoV-2 (new coronavirus) can be transmitted by droplets that escape the lungs through coughing or sneezing and infect humans (direct transmission), or they are deposited in surfaces and infect humans when in contact with this contaminated surface (indirect transmission) [<xref rid="pone.0252271.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0252271.ref002" ref-type="bibr">2</xref>]. These transmission routes resulted in a rapid spreading of this virus, and the World Health Organization (WHO) declared CoViD-19 a pandemic on March 11, 2020. In general, the fatality rate in elder patients (60 years or more) is much higher than those with 60 years or less [<xref rid="pone.0252271.ref003" ref-type="bibr">3</xref>].</p>
              <p>Currently, there is not a vaccine neither an effective treatment. Hence, at the beginning of CoViD-19 outbreaks, quarantine was the primary way of controlling the dissemination of the new coronavirus in a population [<xref rid="pone.0252271.ref004" ref-type="bibr">4</xref>]. However, there is evidence that individual (protection of mouth and nose using face mask and protection of eyes, and washing hands with alcohol and gel) and collective (social distancing) protective measures diminish the transmission of CoViD-19 [<xref rid="pone.0252271.ref005" ref-type="bibr">5</xref>]. The decrease in the incidence of CoViD-19 by quarantine, known as flattening the curve of an epidemic, can be quantified by mathematical modeling.</p>
              <p>Initially, computational models (especially, agent-based model) to describe the influenza epidemic were adapted and applied to estimate the spreading of SARS-CoV-2. Koo <italic toggle="yes">et al</italic>. [<xref rid="pone.0252271.ref006" ref-type="bibr">6</xref>] used such a model to study the propagation of the new coronavirus in Singapore, assuming that the basic reproduction number, denoted by <italic toggle="yes">R</italic><sub>0</sub>, was around 2. The same approach was made by Ferguson <italic toggle="yes">et al</italic>. [<xref rid="pone.0252271.ref007" ref-type="bibr">7</xref>] to investigate the impact of non-pharmaceutical interventions (isolation of susceptible persons) named mitigation and suppression. Briefly, mitigation reduces the basic reproduction number <italic toggle="yes">R</italic><sub>0</sub> but not lower than one, while suppression reduces the basic reproduction number lower than one. Their model was simulated assuming <italic toggle="yes">R</italic><sub>0</sub> around 2.5, and predicted the numbers of severe cases and deaths due to CoViD-19 without interventions and compared them with those numbers when implemented quarantine (mitigation or suppression) in a population. However, instead of assuming a specific value for <italic toggle="yes">R</italic><sub>0</sub>, Li <italic toggle="yes">et al</italic>. [<xref rid="pone.0252271.ref008" ref-type="bibr">8</xref>] performed a stochastic simulation of SEIR (susceptible, exposed, infectious, and recovered compartments) model incorporating the rapid dissemination of new coronavirus due to undocumented infections. They estimated the effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> around 2.4. In the SEIR model, the severe CoViD-19 cases were used to estimate the basic reproduction number <italic toggle="yes">R</italic><sub>0</sub>; however, those individuals are isolated in hospitals receiving treatment [<xref rid="pone.0252271.ref009" ref-type="bibr">9</xref>].</p>
              <p>Mathematical models based on a well-documented natural history of the disease allow us to understand the progression of viral infection and provide mathematical expression to estimate <italic toggle="yes">R</italic><sub>0</sub>, which is related to the magnitude of efforts to eradicate an infection [<xref rid="pone.0252271.ref010" ref-type="bibr">10</xref>]. When a simple SIR model is considered to describe the CoViD-19 epidemic, it is expected to estimate <italic toggle="yes">R</italic><sub>0</sub> around 2. Fortunately, the knowledge about the natural history of CoViD-19 is being improved every day as the epidemic evolves. Consequently, incorporating novel aspects of this epidemic can benefit mathematical modeling. In Yang <italic toggle="yes">et al</italic>. [<xref rid="pone.0252271.ref011" ref-type="bibr">11</xref>], a mathematical model encompassing two subpopulations based on the different fatality rates in young (60 years old or less) and elder (60 years old or more) subpopulations was developed aiming to study the impacts of the quarantine and further relaxation (release) on the epidemic of CoViD-19. That model was applied to São Paulo State (Brazil) to describe the epidemiological scenario considering intermittent pulses in isolation and release. The isolation of the susceptible persons (non-pharmaceutical interventions [<xref rid="pone.0252271.ref007" ref-type="bibr">7</xref>]) jumps down <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> as the herd immunity jumps it down by the vaccination [<xref rid="pone.0252271.ref010" ref-type="bibr">10</xref>].</p>
              <p>We improved the model presented in [<xref rid="pone.0252271.ref011" ref-type="bibr">11</xref>], allowing the transmission of the infection by persons manifesting mild CoViD-19 symptoms and incorporating the protective measures that reduced the virus’s transmission. Briefly, the model considers susceptible, exposed, asymptomatic, pre-symptomatic, mild CoViD-19, severe CoViD-19, and recovered compartments based on the natural history of CoViD-19. The general model also considers the compartments of isolated persons and those who were caught by test. The protection conferred to susceptible persons by quarantine and by adopting protective measures by the non-isolated (circulating) subpopulation is named “herd protection”. The model proposed here is applied to evaluate the impacts of herd protection on the epidemic in São Paulo State and Spain.</p>
              <p>The widespread of CoViD-19 in Spain led to adopting a rigid quarantine (lockdown, hereafter), which is an extreme measure to control an epidemic’s quick increase [<xref rid="pone.0252271.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0252271.ref013" ref-type="bibr">13</xref>]. São Paulo State, however, implemented a partial quarantine (isolation, hereafter) in the population to avoid critical epidemiological scenarios that occurred in Spain [<xref rid="pone.0252271.ref014" ref-type="bibr">14</xref>] and Italy [<xref rid="pone.0252271.ref015" ref-type="bibr">15</xref>]. Based on the data collection of severe CoViD-19 cases and deaths from São Paulo State and Spain, we aim to estimate the model parameters, the proportion of the population in isolation/lockdown, and the reduction in the transmission rates by adopting the protective measures. The estimated parameters allow us to calculate the basic reproduction number <italic toggle="yes">R</italic><sub>0</sub> for São Paulo State and Spain and compare the CoViD-19 epidemiological scenarios yielded in both regions.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Materials and methods</title>
              <p>We present a general model to describe the CoViD-19 epidemic considering the quarantine and relaxation. However, to characterize the epidemic restricted to the quarantine, the system of Eqs (A.2-A.4) in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref> is reduced by dropping out the relaxation (<italic toggle="yes">l</italic><sub><italic toggle="yes">ij</italic></sub> = 0) as well as the isolation due to mass test (<italic toggle="yes">η</italic><sub><italic toggle="yes">j</italic></sub> = <italic toggle="yes">η</italic><sub>1<italic toggle="yes">j</italic></sub> = <italic toggle="yes">η</italic><sub>2<italic toggle="yes">j</italic></sub> = 0), treatment (<italic toggle="yes">θ</italic><sub><italic toggle="yes">j</italic></sub> = 0), and educational campaign (<inline-formula id="pone.0252271.e001"><alternatives><graphic xlink:href="pone.0252271.e001.jpg" id="pone.0252271.e001g" position="anchor"/><mml:math id="M1" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>ϖ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>), with <italic toggle="yes">j</italic> = <italic toggle="yes">y</italic>, <italic toggle="yes">o</italic>. The description of the model variables and parameters are given in Section A.1 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>. In <xref rid="pone.0252271.t001" ref-type="table">Table 1</xref>, we summarize the model classes (or variables) of the reduced model.</p>
              <table-wrap position="float" id="pone.0252271.t001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0252271.t001</object-id>
                <label>Table 1</label>
                <caption>
                  <title>Summary of the model variables (<italic toggle="yes">j</italic> = <italic toggle="yes">y</italic>, <italic toggle="yes">o</italic>).</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0252271.t001" id="pone.0252271.t001g" position="float"/>
                  <table frame="box" rules="all" border="0">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1">Symbol</th>
                        <th align="left" rowspan="1" colspan="1">Meaning</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">S</italic>
                          <sub>
                            <italic toggle="yes">j</italic>
                          </sub>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Susceptible persons</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">Q</italic>
                          <sub>
                            <italic toggle="yes">j</italic>
                          </sub>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Isolated among susceptible persons</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">E</italic>
                          <sub>
                            <italic toggle="yes">j</italic>
                          </sub>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Exposed and incubating new coronavirus persons</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">A</italic>
                          <sub>
                            <italic toggle="yes">j</italic>
                          </sub>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Asymptomatic persons</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">D</italic>
                          <sub>1<italic toggle="yes">j</italic></sub>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Pre-diseased (pre-symptomatic) persons</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">Q</italic>
                          <sub>2<italic toggle="yes">j</italic></sub>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Mild (non-hospitalized) CoViD-19 persons</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">D</italic>
                          <sub>2<italic toggle="yes">j</italic></sub>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Severe (hospitalized) CoViD-19 persons</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">I</italic>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Immune (recovered) persons</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
              </table-wrap>
              <p>In <xref rid="pone.0252271.t002" ref-type="table">Table 2</xref>, we summarize the reduced model parameters. The description of the assigned values (for elder classes, values are between parentheses) can be found in Section D.2 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>. The transmission rates <italic toggle="yes">β</italic><sub>1<italic toggle="yes">j</italic></sub>, <italic toggle="yes">β</italic><sub>2<italic toggle="yes">j</italic></sub>, and <italic toggle="yes">β</italic><sub>3<italic toggle="yes">j</italic></sub>, additional mortality rate <italic toggle="yes">α</italic><sub><italic toggle="yes">j</italic></sub>, the proportion in isolation <italic toggle="yes">k</italic><sub><italic toggle="yes">j</italic></sub>, with <italic toggle="yes">j</italic> = <italic toggle="yes">y</italic>, <italic toggle="yes">o</italic>, and the protection and reduction factors <italic toggle="yes">ε</italic> and <italic toggle="yes">ω</italic> are estimated in the next section.</p>
              <table-wrap position="float" id="pone.0252271.t002">
                <object-id pub-id-type="doi">10.1371/journal.pone.0252271.t002</object-id>
                <label>Table 2</label>
                <caption>
                  <title>Summary of the reduced model parameters (<italic toggle="yes">j</italic> = <italic toggle="yes">y</italic>, <italic toggle="yes">o</italic>) and values (rates in <italic toggle="yes">days</italic><sup>−1</sup>, time in <italic toggle="yes">days</italic> and proportions are dimensionless).</title>
                  <p>Some values are calculated (<sup>#</sup>) or assumed (<sup>$</sup>) or obtained from the liteature (*) or estimated (**). The values (<sup>&amp;</sup>) correspond to São Paulo State. For Spain, <italic toggle="yes">ϕ</italic> = <italic toggle="yes">μ</italic> = 1/(83.4 × 365) <italic toggle="yes">days</italic><sup>−1</sup>, <italic toggle="yes">φ</italic> = 1.14 × 10<sup>−5</sup>
<italic toggle="yes">days</italic><sup>−1</sup>, and <italic toggle="yes">τ</italic><sup><italic toggle="yes">is</italic></sup> is March 16.</p>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0252271.t002" id="pone.0252271.t002g" position="float"/>
                  <table frame="box" rules="all" border="0">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1">Symbol</th>
                        <th align="left" rowspan="1" colspan="1">Meaning</th>
                        <th align="left" rowspan="1" colspan="1">Value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">μ</italic>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Natural mortality rate</td>
                        <td align="left" rowspan="1" colspan="1">1/(78.4 × 365)*<sup>&amp;</sup></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">ϕ</italic>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Birth rate</td>
                        <td align="left" rowspan="1" colspan="1">1/(78.4 × 365)*<sup>&amp;</sup></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">φ</italic>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Aging rate</td>
                        <td align="left" rowspan="1" colspan="1">6.7 × 10<sup>−6#&amp;</sup></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">σ</italic><sub><italic toggle="yes">y</italic></sub>(<italic toggle="yes">σ</italic><sub><italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Incubation rate</td>
                        <td align="left" rowspan="1" colspan="1">1/5.8(1/5.8)<sup>#</sup></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">γ</italic><sub><italic toggle="yes">y</italic></sub>(<italic toggle="yes">γ</italic><sub><italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Recovery rate of asymptomatic persons</td>
                        <td align="left" rowspan="1" colspan="1">1/12(1/14)*</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">γ</italic><sub>1<italic toggle="yes">y</italic></sub>(<italic toggle="yes">γ</italic><sub>1<italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Infection rate of pre-diseased persons</td>
                        <td align="left" rowspan="1" colspan="1">1/4(1/4)*</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">γ</italic><sub>2<italic toggle="yes">y</italic></sub>(<italic toggle="yes">γ</italic><sub>2<italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Recovery rate of severe CoViD-19</td>
                        <td align="left" rowspan="1" colspan="1">1/12(1/21)*</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">γ</italic><sub>3<italic toggle="yes">y</italic></sub>(<italic toggle="yes">γ</italic><sub>3<italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Infection rate of mild CoViD-19 persons</td>
                        <td align="left" rowspan="1" colspan="1">1/13(1/16)*</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">τ</italic>
                          <sup>
                            <italic toggle="yes">is</italic>
                          </sup>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Time of the introduction of isolation</td>
                        <td align="left" rowspan="1" colspan="1">March 24*<sup>&amp;</sup></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">z</italic><sub><italic toggle="yes">y</italic></sub>(<italic toggle="yes">z</italic><sub><italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Proportion of transmission by mild CoViD-19 persons</td>
                        <td align="left" rowspan="1" colspan="1">0.5(0.2)<sup>$</sup></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">χ</italic><sub><italic toggle="yes">y</italic></sub>(<italic toggle="yes">χ</italic><sub><italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Proportion of remaining as asymptomatic persons</td>
                        <td align="left" rowspan="1" colspan="1">0.98(0.95)<sup>$</sup></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic><sub><italic toggle="yes">y</italic></sub>(<italic toggle="yes">p</italic><sub><italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Proportion of asymptomatic persons</td>
                        <td align="left" rowspan="1" colspan="1">0.8(0.8)<sup>#</sup></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">m</italic><sub><italic toggle="yes">y</italic></sub>(<italic toggle="yes">m</italic><sub><italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Proportion of mild (non-hospitalized) CoViD-19</td>
                        <td align="left" rowspan="1" colspan="1">0.92(0.75)<sup>#</sup></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">ε</italic>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Protection factor</td>
                        <td align="left" rowspan="1" colspan="1">**</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">ω</italic>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Reduction factor</td>
                        <td align="left" rowspan="1" colspan="1">**</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">k</italic><sub><italic toggle="yes">y</italic></sub>(<italic toggle="yes">k</italic><sub><italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Proportion in isolation</td>
                        <td align="left" rowspan="1" colspan="1">**</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">α</italic><sub><italic toggle="yes">y</italic></sub>(<italic toggle="yes">α</italic><sub><italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Additional mortality rate</td>
                        <td align="left" rowspan="1" colspan="1">**</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">β</italic><sub>1<italic toggle="yes">y</italic></sub>(<italic toggle="yes">β</italic><sub>1<italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Transmission rate due to asymptomatic persons</td>
                        <td align="left" rowspan="1" colspan="1">**</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">β</italic><sub>2<italic toggle="yes">y</italic></sub>(<italic toggle="yes">β</italic><sub>2<italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Transmission rate due to pre-diseased persons</td>
                        <td align="left" rowspan="1" colspan="1">**</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">β</italic><sub>3<italic toggle="yes">y</italic></sub>(<italic toggle="yes">β</italic><sub>3<italic toggle="yes">o</italic></sub>)</td>
                        <td align="left" rowspan="1" colspan="1">Transmission rate due to mild CoViD-19 persons</td>
                        <td align="left" rowspan="1" colspan="1">**</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
              </table-wrap>
              <p>Therefore, the reduced model has the equations for susceptible individuals
<disp-formula id="pone.0252271.e002"><alternatives><graphic xlink:href="pone.0252271.e002.jpg" id="pone.0252271.e002g" position="anchor"/><mml:math id="M2" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>ϕ</mml:mi><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mo>(</mml:mo><mml:mi>φ</mml:mi><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>)</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mo>λ</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mi>δ</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msubsup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>φ</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mo>λ</mml:mo><mml:mi>ψ</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mi>δ</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msubsup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(1)</label></disp-formula>
for isolated and infectious individuals, with <italic toggle="yes">j</italic> = <italic toggle="yes">y</italic>, <italic toggle="yes">o</italic>,
<disp-formula id="pone.0252271.e003"><alternatives><graphic xlink:href="pone.0252271.e003.jpg" id="pone.0252271.e003g" position="anchor"/><mml:math id="M3" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mi>δ</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msubsup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mi>Q</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>E</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>λ</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>ψ</mml:mi><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>)</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>A</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>)</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>)</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>)</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>)</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>A</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>)</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>)</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>)</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(2)</label></disp-formula>
and for recovered individuals,
<disp-formula id="pone.0252271.e004"><alternatives><graphic xlink:href="pone.0252271.e004.jpg" id="pone.0252271.e004g" position="anchor"/><mml:math id="M4" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:msub><mml:mi>γ</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:msub><mml:mi>A</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:msub><mml:mi>γ</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:msub><mml:mi>A</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>μ</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(3)</label></disp-formula>
where <italic toggle="yes">N</italic><sub><italic toggle="yes">j</italic></sub> = <italic toggle="yes">S</italic><sub><italic toggle="yes">j</italic></sub> + <italic toggle="yes">E</italic><sub><italic toggle="yes">j</italic></sub> + <italic toggle="yes">A</italic><sub><italic toggle="yes">j</italic></sub> + <italic toggle="yes">D</italic><sub>1<italic toggle="yes">j</italic></sub> + <italic toggle="yes">Q</italic><sub>2<italic toggle="yes">j</italic></sub> + <italic toggle="yes">D</italic><sub>2<italic toggle="yes">j</italic></sub>, and <italic toggle="yes">N</italic> = <italic toggle="yes">N</italic><sub><italic toggle="yes">y</italic></sub> + <italic toggle="yes">N</italic><sub><italic toggle="yes">o</italic></sub> + <italic toggle="yes">I</italic> obeys Eq (A.5) in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>. The force of infection λ is given by Eq (A.1) in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>.</p>
              <p>The system of non-autonomous and non-linear differential Eqs (<xref rid="pone.0252271.e002" ref-type="disp-formula">1</xref>–<xref rid="pone.0252271.e004" ref-type="disp-formula">3</xref>) is simulated permitting pulse intervention to the boundary conditions. Hence, the equations for susceptible and isolated persons become
<disp-formula id="pone.0252271.e005"><alternatives><graphic xlink:href="pone.0252271.e005.jpg" id="pone.0252271.e005g" position="anchor"/><mml:math id="M5" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>ϕ</mml:mi><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mo>(</mml:mo><mml:mi>φ</mml:mi><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>)</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mo>λ</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>φ</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mo>λ</mml:mo><mml:mi>ψ</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>Q</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>−</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mi>Q</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(4)</label></disp-formula>
<italic toggle="yes">j</italic> = <italic toggle="yes">y</italic>, <italic toggle="yes">o</italic>, and other equations are the same. Hence, for the system of Eqs (<xref rid="pone.0252271.e002" ref-type="disp-formula">1</xref>–<xref rid="pone.0252271.e004" ref-type="disp-formula">3</xref>), the initial conditions (at <italic toggle="yes">t</italic> = 0) are, for <italic toggle="yes">j</italic> = <italic toggle="yes">y</italic>, <italic toggle="yes">o</italic>,
<disp-formula id="pone.0252271.e006"><alternatives><graphic xlink:href="pone.0252271.e006.jpg" id="pone.0252271.e006g" position="anchor"/><mml:math id="M6" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mtext>where</mml:mtext></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>I</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(5)</label></disp-formula>
where <italic toggle="yes">N</italic><sub>0<italic toggle="yes">y</italic></sub> and <italic toggle="yes">N</italic><sub>0<italic toggle="yes">o</italic></sub> are the size of young and elder subpopulations, with <italic toggle="yes">N</italic>(0) = <italic toggle="yes">N</italic><sub>0</sub> = <italic toggle="yes">N</italic><sub>0<italic toggle="yes">y</italic></sub> + <italic toggle="yes">N</italic><sub>0<italic toggle="yes">o</italic></sub>, and <inline-formula id="pone.0252271.e007"><alternatives><graphic xlink:href="pone.0252271.e007.jpg" id="pone.0252271.e007g" position="anchor"/><mml:math id="M7" display="inline" overflow="scroll"><mml:msub><mml:mi>n</mml:mi><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msub></mml:math></alternatives></inline-formula> is a non-negative number. For instance, <inline-formula id="pone.0252271.e008"><alternatives><graphic xlink:href="pone.0252271.e008.jpg" id="pone.0252271.e008g" position="anchor"/><mml:math id="M8" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>y</mml:mi></mml:msub></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>o</mml:mi></mml:msub></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> means that there is not any exposed person (young and elder) at the beginning of the epidemic.</p>
              <p>The boundary conditions describing the quarantine implemented at <italic toggle="yes">t</italic> = <italic toggle="yes">τ</italic><sup><italic toggle="yes">is</italic></sup> are
<disp-formula id="pone.0252271.e009"><alternatives><graphic xlink:href="pone.0252271.e009.jpg" id="pone.0252271.e009g" position="anchor"/><mml:math id="M9" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>(</mml:mo><mml:msup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>(</mml:mo><mml:msup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mtext>and</mml:mtext></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>(</mml:mo><mml:msup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>(</mml:mo><mml:msup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>(</mml:mo><mml:msup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(6)</label></disp-formula>
plus
<disp-formula id="pone.0252271.e010"><alternatives><graphic xlink:href="pone.0252271.e010.jpg" id="pone.0252271.e010g" position="anchor"/><mml:math id="M10" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>(</mml:mo><mml:msup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>(</mml:mo><mml:msup><mml:mi>τ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mtext>where</mml:mtext></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>I</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(7)</label></disp-formula>
where we have <italic toggle="yes">τ</italic><sup><italic toggle="yes">is</italic>−</sup> = lim<sub><italic toggle="yes">t</italic>→<italic toggle="yes">τ</italic><sup><italic toggle="yes">is</italic></sup></sub>
<italic toggle="yes">t</italic> (for <italic toggle="yes">t</italic> &lt; <italic toggle="yes">τ</italic><sup><italic toggle="yes">is</italic></sup>), and <italic toggle="yes">τ</italic><sup><italic toggle="yes">is</italic>+</sup> = lim<sub><italic toggle="yes">τ</italic><sup><italic toggle="yes">is</italic></sup>←<italic toggle="yes">t</italic></sub>
<italic toggle="yes">t</italic> (for <italic toggle="yes">t</italic> &gt; <italic toggle="yes">τ</italic><sup><italic toggle="yes">is</italic></sup>). If quarantine is applied to a completely susceptible population at <italic toggle="yes">t</italic> = 0, there are not any infectious persons, so <italic toggle="yes">S</italic>(0) = <italic toggle="yes">N</italic><sub>0</sub>. If quarantine is done at <inline-formula id="pone.0252271.e011"><alternatives><graphic xlink:href="pone.0252271.e011.jpg" id="pone.0252271.e011g" position="anchor"/><mml:math id="M11" display="inline" overflow="scroll"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:msubsup><mml:mi>τ</mml:mi><mml:mi>j</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> without a screening of persons harboring the virus, then many of the asymptomatic persons could be isolated with susceptible persons.</p>
              <p>The epidemiological scenario of quarantine is obtained by the solution of the system of Eqs (<xref rid="pone.0252271.e002" ref-type="disp-formula">1</xref>–<xref rid="pone.0252271.e004" ref-type="disp-formula">3</xref>). The simulation of this system provides the epidemic curve (severe CoViD-19 cases <italic toggle="yes">D</italic><sub>2</sub>), and the numbers of susceptible (<italic toggle="yes">S</italic>) and recovered (<italic toggle="yes">I</italic>) persons. However, the following epidemiological parameters (the initial conditions (<xref rid="pone.0252271.e006" ref-type="disp-formula">5</xref>) supplied to the system of equations determine all initial conditions below) are derived:</p>
              <p><bold>(1)</bold> The number of non-isolated (circulating) persons <italic toggle="yes">S</italic><sub><italic toggle="yes">j</italic></sub> is obtained from <xref rid="pone.0252271.e005" ref-type="disp-formula">Eq (4)</xref>, and the number of circulating plus isolated susceptible persons <italic toggle="yes">S</italic><sup><italic toggle="yes">tot</italic></sup> is obtained by
<disp-formula id="pone.0252271.e012"><alternatives><graphic xlink:href="pone.0252271.e012.jpg" id="pone.0252271.e012g" position="anchor"/><mml:math id="M12" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mrow><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd/><mml:mtd><mml:mtext>with</mml:mtext></mml:mtd><mml:mtd/><mml:mtd><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mi>y</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mrow><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(8)</label></disp-formula>
where <inline-formula id="pone.0252271.e013"><alternatives><graphic xlink:href="pone.0252271.e013.jpg" id="pone.0252271.e013g" position="anchor"/><mml:math id="M13" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e014"><alternatives><graphic xlink:href="pone.0252271.e014.jpg" id="pone.0252271.e014g" position="anchor"/><mml:math id="M14" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> are the numbers of susceptible, respectively, young and elder persons.</p>
              <p><bold>(2)</bold> The numbers of new cases of CoViD-19 Φ<sub><italic toggle="yes">y</italic></sub> and Φ<sub><italic toggle="yes">y</italic></sub> are
<disp-formula id="pone.0252271.e015"><alternatives><graphic xlink:href="pone.0252271.e015.jpg" id="pone.0252271.e015g" position="anchor"/><mml:math id="M15" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mo>Φ</mml:mo><mml:mi>y</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>λ</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>y</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mo>Φ</mml:mo><mml:mi>o</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>λ</mml:mo><mml:mi>ψ</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd><mml:mtd><mml:mtext>with</mml:mtext></mml:mtd><mml:mtd><mml:mrow><mml:mo>Φ</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mo>Φ</mml:mo><mml:mi>y</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mo>Φ</mml:mo><mml:mi>o</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(9)</label></disp-formula>
where Φ<sub><italic toggle="yes">y</italic></sub>(0) = <italic toggle="yes">E</italic><sub><italic toggle="yes">y</italic></sub>(0) and Φ<sub><italic toggle="yes">o</italic></sub>(0) = <italic toggle="yes">E</italic><sub><italic toggle="yes">o</italic></sub>(0).</p>
              <p><bold>(3)</bold> The numbers of accumulated severe CoViD-19 cases Ω<sub><italic toggle="yes">y</italic></sub> and Ω<sub><italic toggle="yes">o</italic></sub> are given by the exits from <italic toggle="yes">D</italic><sub>1<italic toggle="yes">y</italic></sub>, <italic toggle="yes">Q</italic><sub>1<italic toggle="yes">y</italic></sub>, <italic toggle="yes">D</italic><sub>1<italic toggle="yes">o</italic></sub>, and <italic toggle="yes">Q</italic><sub>1<italic toggle="yes">o</italic></sub>, and entering into classes <italic toggle="yes">D</italic><sub>2<italic toggle="yes">y</italic></sub> and <italic toggle="yes">D</italic><sub>2<italic toggle="yes">o</italic></sub>, that is,
<disp-formula id="pone.0252271.e016"><alternatives><graphic xlink:href="pone.0252271.e016.jpg" id="pone.0252271.e016g" position="anchor"/><mml:math id="M16" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mo>Ω</mml:mo><mml:mi>y</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>)</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mo>Ω</mml:mo><mml:mi>o</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>)</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd><mml:mtd><mml:mtext>with</mml:mtext></mml:mtd><mml:mtd><mml:mrow><mml:mo>Ω</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mo>Ω</mml:mo><mml:mi>y</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mo>Ω</mml:mo><mml:mi>o</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(10)</label></disp-formula>
with Ω<sub><italic toggle="yes">y</italic></sub>(0) = Ω<sub><italic toggle="yes">y</italic>0</sub> and Ω<sub><italic toggle="yes">o</italic></sub>(0) = Ω<sub><italic toggle="yes">o</italic>0</sub>. The daily severe CoViD-19 cases Ω<sub><italic toggle="yes">d</italic></sub> is, considering Δ<italic toggle="yes">t</italic> = <italic toggle="yes">t</italic><sub><italic toggle="yes">i</italic></sub> − <italic toggle="yes">t</italic><sub><italic toggle="yes">i</italic>−1</sub> = Δ<italic toggle="yes">t</italic> = 1 <italic toggle="yes">day</italic>,
<disp-formula id="pone.0252271.e017"><alternatives><graphic xlink:href="pone.0252271.e017.jpg" id="pone.0252271.e017g" position="anchor"/><mml:math id="M17" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mo>Ω</mml:mo><mml:mi>d</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munderover><mml:mo>∫</mml:mo><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:munderover><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>Ω</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>Ω</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:mo>Ω</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(11)</label></disp-formula>
where Ω<sub><italic toggle="yes">d</italic></sub>(0) = Ω<sub><italic toggle="yes">d</italic>0</sub> is the first observed CoViD-19 case at <italic toggle="yes">t</italic><sub>0</sub> = 0, with <italic toggle="yes">i</italic> = 1, 2, ⋯, and <italic toggle="yes">t</italic><sub>1</sub> = 1 is the next day in the calendar time, and so on.</p>
              <p><bold>(4)</bold> The number of deaths due to severe CoViD-19 cases is
<disp-formula id="pone.0252271.e018"><alternatives><graphic xlink:href="pone.0252271.e018.jpg" id="pone.0252271.e018g" position="anchor"/><mml:math id="M18" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mo>Π</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mo>Π</mml:mo><mml:mi>y</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mo>Π</mml:mo><mml:mi>o</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mtext>where</mml:mtext></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mo>Π</mml:mo><mml:mi>y</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mtext>with</mml:mtext></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mo>Π</mml:mo><mml:mi>y</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mo>Π</mml:mo><mml:mi>o</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:mtd><mml:mtd columnalign="left"><mml:mtext>with</mml:mtext></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mo>Π</mml:mo><mml:mi>o</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(12)</label></disp-formula>
In the estimation of the additional mortality rates, we must bear in mind that the registration times of the new cases and deaths do not have direct correspondence, somewhat they are delayed by Δ days, that is, Π<sub><italic toggle="yes">y</italic></sub>(<italic toggle="yes">t</italic> + Δ) = <italic toggle="yes">α</italic><sub><italic toggle="yes">y</italic></sub><italic toggle="yes">D</italic><sub>2<italic toggle="yes">y</italic></sub>(<italic toggle="yes">t</italic>), for instance. We can estimate the severity case fatality rate as the quotient Π/Ω, and the infection fatality rate as Π/Φ.</p>
              <p>The model parameters are estimated using the registered data from São Paulo State (February 26 to May 7, 2020) and Spain (January 31 to May 20, 2020). We calculate the basic (<italic toggle="yes">R</italic><sub>0</sub>) and effective (<italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub>) reproduction numbers obtained from the analysis of the steady-state corresponding to the system of Eqs (A.2-A.4) in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, which are found in Section A.2 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>. We perform the sensitivity analysis of <italic toggle="yes">R</italic><sub>0</sub>, which is given in Section A.3 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>.</p>
            </sec>
            <sec sec-type="results" id="sec003">
              <title>Results</title>
              <p>In the preceding section, we presented a mathematical model to describe the transmission of SARS-CoV-2, which is applied to describe the epidemiological scenarios of isolation in São Paulo State and lockdown in Spain. We obtained the basic reproduction number <italic toggle="yes">R</italic><sub>0</sub> and the effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> (see Section A.2 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>).</p>
              <p>In Section B in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, the accumulated CoViD-19 data follow three distinct trends. These periods in São Paulo State describe the epidemic occurring naturally, with isolation, and isolation associated with protective measures. In Spain, the three periods represent the natural epidemic, the epidemic during the transition from natural to lockdown, and the epidemic occurring in lockdown. Considering these three trends shown by the CoViD-19 data, we evaluate the model parameters (see Section C in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>).</p>
              <p>It is worth stressing that the first period of data corresponding to the natural epidemic of CoViD-19 in São Paulo State and Spain is a unique opportunity to estimate <italic toggle="yes">R</italic><sub>0</sub>. It is in concordance with the definition of the basic reproduction number: Completely susceptible population without constraints (interventions) [<xref rid="pone.0252271.ref010" ref-type="bibr">10</xref>]. Based on this estimation, all subsequent non-pharmaceutical interventions (herd protection) applied to flattening the epidemic curve can be assessed. In the preceding section, we described the quarantine as a pulse, resulting in a sharp fall (jump down) in the effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub>, as observed in pulse vaccination [<xref rid="pone.0252271.ref010" ref-type="bibr">10</xref>]. We estimate the magnitude of the jump down in <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> due to the quarantine and protective measures.</p>
              <sec id="sec004">
                <title>CoViD-19 in São Paulo State—Isolation</title>
                <p>São Paulo State has 44.6 million inhabitants with 15.3% of elder population (60 years old or more) [<xref rid="pone.0252271.ref016" ref-type="bibr">16</xref>], and the demographic density is 177/<italic toggle="yes">km</italic><sup>2</sup> [<xref rid="pone.0252271.ref017" ref-type="bibr">17</xref>]. The first confirmed case of CoViD-19 occurred on February 26, the first death due to CoViD-19 on March 16, and on March 24, São Paulo State implemented the isolation of people in non-essential activities.</p>
                <p>In Section C.1 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, we evaluate the model parameters based on the daily collected data (see B.1 and B.2 Figs in Section B.1 of <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>), using the estimation method described in Section D.1 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>. We summarize the estimated values using data from February 26 to May 7 (see C.1-C.4 Figs in Section C.1 of <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>):
<list list-type="order"><list-item><p>Data from February 26 to April 3—The transmission rates <italic toggle="yes">β</italic><sub><italic toggle="yes">y</italic></sub> = 0.78 and <italic toggle="yes">β</italic><sub><italic toggle="yes">o</italic></sub> = 0.90 (both in <italic toggle="yes">days</italic><sup>−1</sup>), giving <italic toggle="yes">R</italic><sub>0</sub> = 9.24; the additional mortality rates <italic toggle="yes">α</italic><sub><italic toggle="yes">y</italic></sub> = 0.00185 and <italic toggle="yes">α</italic><sub><italic toggle="yes">o</italic></sub> = 0.0071 (both in <italic toggle="yes">days</italic><sup>−1</sup>).</p></list-item><list-item><p>Data from March 24 to April 12—The proportion in isolation of susceptible persons <italic toggle="yes">k</italic> = 0.53.</p></list-item><list-item><p>Data from April 4 to May 7—The protective factor <italic toggle="yes">ε</italic> = 0.5 reducing the transmission rates to <inline-formula id="pone.0252271.e019"><alternatives><graphic xlink:href="pone.0252271.e019.jpg" id="pone.0252271.e019g" position="anchor"/><mml:math id="M19" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>β</mml:mi><mml:mi>y</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.39</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e020"><alternatives><graphic xlink:href="pone.0252271.e020.jpg" id="pone.0252271.e020g" position="anchor"/><mml:math id="M20" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>β</mml:mi><mml:mi>o</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.45</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> (both in <italic toggle="yes">days</italic><sup>−1</sup>).</p></list-item></list></p>
                <p>Using these values, we describe the epidemiological scenario of isolation associated with protective measures.</p>
                <p>In <xref rid="pone.0252271.g001" ref-type="fig">Fig 1</xref>, we show the effects of interventions on the dynamic of the new coronavirus. As interventions are added (isolation followed by protective measures), we observe decreasing in the peaks of severe CoViD-19 <italic toggle="yes">D</italic><sub>2</sub>, which move to the right. <xref rid="pone.0252271.g001" ref-type="fig">Fig 1(a)</xref> shows the natural epidemic, epidemic considering only isolation, and epidemic occurring with isolation associated with protective measures. In <xref rid="pone.0252271.g001" ref-type="fig">Fig 1(b)</xref>, we show the number of immune (recovered) persons <italic toggle="yes">I</italic> corresponding to the three cases shown in <xref rid="pone.0252271.g001" ref-type="fig">Fig 1(a)</xref>. The curves of <italic toggle="yes">I</italic> have a sigmoid shape.</p>
                <fig position="float" id="pone.0252271.g001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0252271.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <p>The curves of the natural epidemic (<italic toggle="yes">k</italic> = 0 and <italic toggle="yes">ε</italic> = 1), epidemic considering only isolation (<italic toggle="yes">k</italic> = 0.53 and <italic toggle="yes">ε</italic> = 1), and epidemic occurring with isolation and protective measures (<italic toggle="yes">k</italic> = 0.53 and <italic toggle="yes">ε</italic> = 0.6) (a), and the number of immune persons <italic toggle="yes">I</italic> (b).</p>
                  </caption>
                  <graphic xlink:href="pone.0252271.g001" position="float"/>
                </fig>
                <p>On June 15, the date proposed to initiate the relaxation of quarantine, in the absence of interventions (<italic toggle="yes">k</italic> = 0 and <italic toggle="yes">ε</italic> = 1), the numbers of immune persons <italic toggle="yes">I</italic><sub><italic toggle="yes">y</italic></sub>, <italic toggle="yes">I</italic><sub><italic toggle="yes">o</italic></sub>, and <italic toggle="yes">I</italic> increase from zero to, respectively, 36.92 million, 6.505 million, and 43.43 million. When interventions (isolation and protective measures) are adopted, the numbers are 6.12 million (16.6%), 1.14 million (16.5%), and 7.26 million (16.7%) on June 15. The percentage between parentheses is the ratio between with and without interventions <italic toggle="yes">I</italic>(<italic toggle="yes">k</italic>, <italic toggle="yes">ε</italic>)/<italic toggle="yes">I</italic>(0, 1).</p>
                <p>In <xref rid="pone.0252271.t003" ref-type="table">Table 3</xref>, we show the peaks of <italic toggle="yes">D</italic><sub>2</sub>. Compared with the natural epidemic, the peaks of the flattened epidemic curves decrease around to 35% and 18% in isolation alone and isolation associated with protective measures. The protective measures yielded an additional decrease of 17%. Another benefit of the protective measures is a further delay in one month to occur the peak.</p>
                <table-wrap position="float" id="pone.0252271.t003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0252271.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>The peaks for young, elder, and total persons in the natural epidemic, isolation alone, and isolation associated with protective measures.</title>
                    <p>The percentage between parentheses is the ratio between with and without interventions <italic toggle="yes">D</italic><sub>2</sub>(<italic toggle="yes">k</italic>, <italic toggle="yes">ε</italic>)/<italic toggle="yes">D</italic><sub>2</sub>(0,1) and the peak’s occurrence date.</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0252271.t003" id="pone.0252271.t003g" position="float"/>
                    <table frame="box" rules="all" border="0">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1">young (<italic toggle="yes">y</italic>)</th>
                          <th align="left" rowspan="1" colspan="1">elder (<italic toggle="yes">o</italic>)</th>
                          <th align="left" rowspan="1" colspan="1">all persons</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Natural epidemic (<italic toggle="yes">k</italic> = 0, <italic toggle="yes">ε</italic> = 1)</td>
                          <td align="left" rowspan="1" colspan="1">224, 200 (May 2)</td>
                          <td align="left" rowspan="1" colspan="1">162, 200 (May 4)</td>
                          <td align="left" rowspan="1" colspan="1">386, 400 (May 3)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Isolation only (<italic toggle="yes">k</italic> = 0.53, <italic toggle="yes">ε</italic> = 1)</td>
                          <td align="left" rowspan="1" colspan="1">77, 320 (34%) (May 21)</td>
                          <td align="left" rowspan="1" colspan="1">60, 020 (37%) (May 22)</td>
                          <td align="left" rowspan="1" colspan="1">137, 200 (36%) (May 21)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Isolation and protection (<italic toggle="yes">k</italic> = 0.53, <italic toggle="yes">ε</italic> = 0.5)</td>
                          <td align="left" rowspan="1" colspan="1">36, 010 (16%) (June 22)</td>
                          <td align="left" rowspan="1" colspan="1">31, 160 (19%) (June 24)</td>
                          <td align="left" rowspan="1" colspan="1">67, 140 (18%) (June 23)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>Due to isolation and protective measures, many people remain as susceptible. In <xref rid="pone.0252271.g002" ref-type="fig">Fig 2</xref> we show the circulating susceptible persons <italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub>, <italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub> and <italic toggle="yes">S</italic> = <italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub> + <italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub> (a), and circulating plus isolated susceptible persons <inline-formula id="pone.0252271.e021"><alternatives><graphic xlink:href="pone.0252271.e021.jpg" id="pone.0252271.e021g" position="anchor"/><mml:math id="M21" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0252271.e022"><alternatives><graphic xlink:href="pone.0252271.e022.jpg" id="pone.0252271.e022g" position="anchor"/><mml:math id="M22" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e023"><alternatives><graphic xlink:href="pone.0252271.e023.jpg" id="pone.0252271.e023g" position="anchor"/><mml:math id="M23" display="inline" overflow="scroll"><mml:mrow><mml:msup><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> (b), using <xref rid="pone.0252271.e012" ref-type="disp-formula">Eq (8)</xref>. Remember that <inline-formula id="pone.0252271.e024"><alternatives><graphic xlink:href="pone.0252271.e024.jpg" id="pone.0252271.e024g" position="anchor"/><mml:math id="M24" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> differs from <italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub> just after the introduction of isolation (March 24).</p>
                <fig position="float" id="pone.0252271.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0252271.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <p>The circulating susceptible young <italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub>, elder <italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub> and total <italic toggle="yes">S</italic> = <italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub> + <italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub> persons (a), and the sum of the circulating and isolated susceptible populations <inline-formula id="pone.0252271.e025"><alternatives><graphic xlink:href="pone.0252271.e025" id="pone.0252271.e025g" position="anchor"/><mml:math id="M25" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0252271.e026"><alternatives><graphic xlink:href="pone.0252271.e026" id="pone.0252271.e026g" position="anchor"/><mml:math id="M26" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e027"><alternatives><graphic xlink:href="pone.0252271.e027" id="pone.0252271.e027g" position="anchor"/><mml:math id="M27" display="inline" overflow="scroll"><mml:mrow><mml:msup><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> (b).</p>
                  </caption>
                  <graphic xlink:href="pone.0252271.g002" position="float"/>
                </fig>
                <p>In <xref rid="pone.0252271.t004" ref-type="table">Table 4</xref>, we show the numbers of susceptible persons <italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub>, <italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub>, and <italic toggle="yes">S</italic> = <italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub> + <italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub> without any interventions (<italic toggle="yes">k</italic> = 0 and <italic toggle="yes">ε</italic> = 1), with interventions (isolation and protective measures), and adding isolated persons <inline-formula id="pone.0252271.e028"><alternatives><graphic xlink:href="pone.0252271.e028.jpg" id="pone.0252271.e028g" position="anchor"/><mml:math id="M28" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0252271.e029"><alternatives><graphic xlink:href="pone.0252271.e029.jpg" id="pone.0252271.e029g" position="anchor"/><mml:math id="M29" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e030"><alternatives><graphic xlink:href="pone.0252271.e030.jpg" id="pone.0252271.e030g" position="anchor"/><mml:math id="M30" display="inline" overflow="scroll"><mml:mrow><mml:msup><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> at the end of the first wave of the epidemic. Observe that, on June 15, the sum of the susceptible persons in circulation and those in isolation is such that there are more than 750 times and 23, 000 times, respectively, susceptible young and elder persons in comparison with epidemic without any intervention. Hence, if all persons are released without planning, the second wave will be intense, infecting much more elder persons. In the absence of vaccine and effective treatment, interventions to reduce the transmission of SARS-CoV-2 must be continued for a long time to avoid the rebounding of the epidemic or a second wave.</p>
                <table-wrap position="float" id="pone.0252271.t004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0252271.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>The numbers of susceptible persons <italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub>, <italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub>, and <italic toggle="yes">S</italic> = <italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub> + <italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub> without and with interventions, and <inline-formula id="pone.0252271.e031"><alternatives><graphic xlink:href="pone.0252271.e031" id="pone.0252271.e031g" position="anchor"/><mml:math id="M31" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0252271.e032"><alternatives><graphic xlink:href="pone.0252271.e032" id="pone.0252271.e032g" position="anchor"/><mml:math id="M32" display="inline" overflow="scroll"><mml:msubsup><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e033"><alternatives><graphic xlink:href="pone.0252271.e033" id="pone.0252271.e033g" position="anchor"/><mml:math id="M33" display="inline" overflow="scroll"><mml:mrow><mml:msup><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> at the end of the first wave of the epidemic.</title>
                    <p>The percentage between parentheses is the ratio between with and without interventions <italic toggle="yes">S</italic>(<italic toggle="yes">k</italic>, <italic toggle="yes">ε</italic>)/<italic toggle="yes">S</italic>(0, 1).</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0252271.t004" id="pone.0252271.t004g" position="float"/>
                    <table frame="box" rules="all" border="0">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1">young (<italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub>)</th>
                          <th align="left" rowspan="1" colspan="1">elder (<italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub>)</th>
                          <th align="left" rowspan="1" colspan="1">all persons (<italic toggle="yes">S</italic><sub><italic toggle="yes">y</italic></sub> + <italic toggle="yes">S</italic><sub><italic toggle="yes">o</italic></sub>)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Natural epidemic</td>
                          <td align="left" rowspan="1" colspan="1">37, 000</td>
                          <td align="left" rowspan="1" colspan="1">210</td>
                          <td align="left" rowspan="1" colspan="1">37, 210</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Isolation and protection (circulating)</td>
                          <td align="left" rowspan="1" colspan="1">8.15 million (22, 027%)</td>
                          <td align="left" rowspan="1" colspan="1">1.3 million (619, 047%)</td>
                          <td align="left" rowspan="1" colspan="1">9.5 million (25, 531%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Isolation and protection (adding isolated)</td>
                          <td align="left" rowspan="1" colspan="1">28 million (75, 676%)</td>
                          <td align="left" rowspan="1" colspan="1">4.9 million (2, 333, 333%)</td>
                          <td align="left" rowspan="1" colspan="1">33 million (88, 686%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>It is essential to estimate the basic reproduction number, which portrays the beginning and ending phases of an epidemic [<xref rid="pone.0252271.ref018" ref-type="bibr">18</xref>]. During the epidemic, however, the effective reproduction number determines the risk of transmission of the infection. We use the approximate effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub>, given by Eq (A.18) in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, to follow the intensity of the epidemic, remembering that <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> &gt; 1 implies epidemic in expansion, while <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> &lt; 1, in contraction. <xref rid="pone.0252271.g003" ref-type="fig">Fig 3</xref> illustrates the effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> and <italic toggle="yes">D</italic><sub>2</sub> during the epidemic, with (a) and without (b) interventions. To be fitted together in the same frame with <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub>, the curve of <italic toggle="yes">D</italic><sub>2</sub> was divided by 7, 000 (a) and 40, 000 (b). The curve of <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> follows the shape of susceptible persons, as shown in <xref rid="pone.0252271.g002" ref-type="fig">Fig 2</xref>, as expected. At the peak of the epidemic, the effective reproduction number is lower than one; hence we have <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 1 occurring on June 14 (a) and April 6 (b).</p>
                <fig position="float" id="pone.0252271.g003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0252271.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <p>The effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> for epidemic with isolation and protective measures (a), and natural epidemic (b) in São Paulo State.</p>
                    <p>The number of severe covid-19 cases <italic toggle="yes">D</italic><sub>2</sub> must be multiplied by 7, 000 (a) and 40, 000 (b).</p>
                  </caption>
                  <graphic xlink:href="pone.0252271.g003" position="float"/>
                </fig>
                <p>As the epidemic evolves, the effective reproduction number varies, as shown in <xref rid="pone.0252271.g003" ref-type="fig">Fig 3(a)</xref>. At the beginning of the epidemic, on February 26, we have <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = <italic toggle="yes">R</italic><sub>0</sub> = 9.24, on March 24, a jump down occurred to <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 4.35 due to the isolation, and a new jump down occurs to <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 2.15 on April 4 when protective measures were adopted. On June 15, when the release will begin, we have <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 0.98, but in the ascending phase of the epidemic. The knowledge of <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> may help public health authorities plan the release strategies.</p>
                <p>We used the accumulated data shown in B.1(b) Fig in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref> and Ω given by <xref rid="pone.0252271.e016" ref-type="disp-formula">Eq (10)</xref> to estimate the transmission rates <italic toggle="yes">β</italic><sub><italic toggle="yes">y</italic></sub> and <italic toggle="yes">β</italic><sub><italic toggle="yes">o</italic></sub>, the proportion in isolation <italic toggle="yes">k</italic>, and the protective factor <italic toggle="yes">ε</italic>. The curve labeled <italic toggle="yes">ε</italic> = 0.5 in C.3(b) Fig in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref> is the estimated curve Ω, from which the curve of severe cases <italic toggle="yes">D</italic><sub>2</sub> was derived, corresponding to the most flattened curve shown in <xref rid="pone.0252271.g001" ref-type="fig">Fig 1(a)</xref>. Now, from the estimated curve of Ω, we derive the daily cases Ω<sub><italic toggle="yes">d</italic></sub> given by <xref rid="pone.0252271.e017" ref-type="disp-formula">Eq (11)</xref>. In <xref rid="pone.0252271.g004" ref-type="fig">Fig 4(a)</xref>, we show the calculated curve Ω<sub><italic toggle="yes">d</italic></sub> and daily cases presented in B.1(a) Fig in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>. In <xref rid="pone.0252271.g004" ref-type="fig">Fig 4(b)</xref>, we show the initial part of the estimated curve Ω with observed data Ω<sup><italic toggle="yes">ob</italic></sup>, the extended Ω<sub><italic toggle="yes">d</italic></sub> and daily observed cases <inline-formula id="pone.0252271.e034"><alternatives><graphic xlink:href="pone.0252271.e034.jpg" id="pone.0252271.e034g" position="anchor"/><mml:math id="M34" display="inline" overflow="scroll"><mml:msubsup><mml:mo>Ω</mml:mo><mml:mi>d</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>, and severe cases <italic toggle="yes">D</italic><sub>2</sub>. The peaks of Ω<sub><italic toggle="yes">d</italic></sub> and <italic toggle="yes">D</italic><sub>2</sub> occur, respectively, on June 12 and 23.</p>
                <fig position="float" id="pone.0252271.g004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0252271.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <p>The calculated curve Ω<sub><italic toggle="yes">d</italic></sub> and observed daily cases in São Paulo State (a), and the initial part of the estimated curve Ω with observed data Ω<sup><italic toggle="yes">ob</italic></sup>, the extended Ω<sub><italic toggle="yes">d</italic></sub> and daily observed cases <inline-formula id="pone.0252271.e035"><alternatives><graphic xlink:href="pone.0252271.e035" id="pone.0252271.e035g" position="anchor"/><mml:math id="M35" display="inline" overflow="scroll"><mml:msubsup><mml:mo>Ω</mml:mo><mml:mi>d</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>, and severe covid-19 cases <italic toggle="yes">D</italic><sub>2</sub> (b).</p>
                  </caption>
                  <graphic xlink:href="pone.0252271.g004" position="float"/>
                </fig>
                <p>On June 12, the peak of the daily cases of CoViD-19 predicted by the model reaches 5, 286. On June 23, the peak of <italic toggle="yes">D</italic><sub>2</sub> estimated by the model is 67, 140, and the number of accumulated cases Ω is 243, 000, which is 362% of the peak of <italic toggle="yes">D</italic><sub>2</sub>, and 63% of cases when the first wave of epidemic ends (386, 700). These values provided by the model correspond to the epidemic with isolation without release.</p>
              </sec>
              <sec id="sec005">
                <title>CoViD-19 in Spain—Lockdown</title>
                <p>Spain has 47.4 million inhabitants [<xref rid="pone.0252271.ref019" ref-type="bibr">19</xref>] with 25.8% of elder population [<xref rid="pone.0252271.ref020" ref-type="bibr">20</xref>], and the demographic density is 92.3/<italic toggle="yes">km</italic><sup>2</sup> [<xref rid="pone.0252271.ref017" ref-type="bibr">17</xref>]. In Spain, the first confirmed case of CoViD-19 occurred on January 31, 2020. However, the daily registering of CoViD-19 began on February 20 (3 cases), the first 28 deaths were registered on March 8 when reached 1, 535 cases, and on March 16, the lockdown was implemented.</p>
                <p>In Section C.2 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, we evaluate the model parameters based on the daily collected data (see B.3 Fig in Section B.2 of <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>), using the estimation method described in Section D.1 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>. We summarize the estimated values using data from January 31 to May 20 (see C.5-C.8 Figs in Section C.8 of <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>):
<list list-type="order"><list-item><p>Data from January 31 to March 21—In the natural epidemic, the estimated values are <italic toggle="yes">β</italic><sub><italic toggle="yes">y</italic></sub> = 0.67 and <italic toggle="yes">β</italic><sub><italic toggle="yes">o</italic></sub> = 0.74 (both in <italic toggle="yes">days</italic><sup>−1</sup>) for the transmission rates, giving <italic toggle="yes">R</italic><sub>0</sub> = 8.0, and the additional mortality rates are <italic toggle="yes">α</italic><sub><italic toggle="yes">y</italic></sub> = 0.00273 and <italic toggle="yes">α</italic><sub><italic toggle="yes">o</italic></sub> = 0.0105 (both in <italic toggle="yes">days</italic><sup>−1</sup>).</p></list-item><list-item><p>Data from March 22 to 28—During the epidemic in transition, for the proportion in the lockdown of susceptible person <italic toggle="yes">k</italic> = 0.9, the estimated transmission rates are <inline-formula id="pone.0252271.e036"><alternatives><graphic xlink:href="pone.0252271.e036.jpg" id="pone.0252271.e036g" position="anchor"/><mml:math id="M36" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>β</mml:mi><mml:mi>y</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.45</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e037"><alternatives><graphic xlink:href="pone.0252271.e037.jpg" id="pone.0252271.e037g" position="anchor"/><mml:math id="M37" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>β</mml:mi><mml:mi>o</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.49</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> (both in <italic toggle="yes">days</italic><sup>−1</sup>) in the isolated population.</p></list-item><list-item><p>Data from March 24 to May 20—In the epidemic during the lockdown, for the protective factor <italic toggle="yes">ε</italic> = 0.5, the estimated transmission rates are <inline-formula id="pone.0252271.e038"><alternatives><graphic xlink:href="pone.0252271.e038.jpg" id="pone.0252271.e038g" position="anchor"/><mml:math id="M38" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>β</mml:mi><mml:mi>y</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.34</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e039"><alternatives><graphic xlink:href="pone.0252271.e039.jpg" id="pone.0252271.e039g" position="anchor"/><mml:math id="M39" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>β</mml:mi><mml:mi>o</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.391</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> (both in <italic toggle="yes">days</italic><sup>−1</sup>) in the circulating population, while in the people in lockdown, for the decreasing factor <italic toggle="yes">ω</italic> = 11.5, <inline-formula id="pone.0252271.e040"><alternatives><graphic xlink:href="pone.0252271.e040.jpg" id="pone.0252271.e040g" position="anchor"/><mml:math id="M40" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>β</mml:mi><mml:mi>y</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.059</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e041"><alternatives><graphic xlink:href="pone.0252271.e041.jpg" id="pone.0252271.e041g" position="anchor"/><mml:math id="M41" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>β</mml:mi><mml:mi>o</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.068</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> (both in <italic toggle="yes">days</italic><sup>−1</sup>).</p></list-item></list></p>
                <p>Using these values, we describe the epidemiological scenario of lockdown associated with protective measures.</p>
                <p>In <xref rid="pone.0252271.g005" ref-type="fig">Fig 5</xref>, we show the effects of interventions on the dynamic of the new coronavirus. During the three phases of the epidemic (natural, in transition, and effective lockdown), we observe a decrease in the peaks of severe CoViD-19 <italic toggle="yes">D</italic><sub>2</sub>, which move to the right. <xref rid="pone.0252271.g005" ref-type="fig">Fig 5(a)</xref> shows the curves representing the natural epidemic, epidemic in transition, and epidemic in effective lockdown. In <xref rid="pone.0252271.g005" ref-type="fig">Fig 5(b)</xref>, we show the number of immune persons <italic toggle="yes">I</italic> corresponding to the three cases shown in <xref rid="pone.0252271.g005" ref-type="fig">Fig 5(a)</xref>. The curves of <italic toggle="yes">I</italic> follow a sigmoid shape.</p>
                <fig position="float" id="pone.0252271.g005">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0252271.g005</object-id>
                  <label>Fig 5</label>
                  <caption>
                    <p>The curves of the natural epidemic (<italic toggle="yes">k</italic> = 0), the epidemic in the transition phase (<italic toggle="yes">k</italic> = 0.9), and the epidemic with lockdown (<italic toggle="yes">k</italic> = 0.9) (a), and the number of immune persons <italic toggle="yes">I</italic> (b).</p>
                  </caption>
                  <graphic xlink:href="pone.0252271.g005" position="float"/>
                </fig>
                <p>In the natural epidemic, the numbers of immune persons <italic toggle="yes">I</italic><sub><italic toggle="yes">y</italic></sub>, <italic toggle="yes">I</italic><sub><italic toggle="yes">o</italic></sub>, and <italic toggle="yes">I</italic> increase from zero to, respectively, 35 million, 12 million, and 47 million on June 15. In the epidemic with lockdown, the numbers are, on June 15, 8.37 million (24%), 3.09 million (25.75%), and 11.46 million (24.38%). <xref rid="pone.0252271.g005" ref-type="fig">Fig 5(b)</xref> shows only <italic toggle="yes">I</italic> with and without interventions. The percentage between parentheses is the ratio between with and without interventions <italic toggle="yes">I</italic>(<italic toggle="yes">k</italic>, <italic toggle="yes">ε</italic>)/<italic toggle="yes">I</italic>(0, 1) on June 15.</p>
                <p>Let us compare the peak of <italic toggle="yes">D</italic><sub>2</sub>. The peaks for young, elder, and total persons in the natural epidemic are, respectively, 202, 600, 272, 700, and 475, 300, occurring on April 13, 15, and 14. In the epidemic with lockdown, the peaks for young, elder, and total persons are, respectively, 32, 850 (16%), 48, 190 (18%), and 80, 750 (17%), which occurred on April 5, 7, and 6. The percentage between parentheses is the ratio between natural epidemic and epidemic with lockdown <italic toggle="yes">D</italic><sub>2</sub>(<italic toggle="yes">k</italic>, <italic toggle="yes">ε</italic>)/<italic toggle="yes">D</italic><sub>2</sub>(0, 1). The lockdown yielded a decrease to 17% compared to the natural epidemic.</p>
                <p><xref rid="pone.0252271.g006" ref-type="fig">Fig 6</xref> shows the effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> and <italic toggle="yes">D</italic><sub>2</sub> during the epidemic in circulating (a) and lockdown (b) populations. To be fitted together in the same frame with <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub>, the curve of <italic toggle="yes">D</italic><sub>2</sub> was divided by 1, 000 (a) and 12, 000 (b).</p>
                <fig position="float" id="pone.0252271.g006">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0252271.g006</object-id>
                  <label>Fig 6</label>
                  <caption>
                    <p>The effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> for epidemic with lockdown in circulating (a) and locked-down (b) population in Spain. The number of severe covid-19 cases <italic toggle="yes">D</italic><sub>2</sub> must be multiplied by 1, 000 (a) and 12, 000 (b).</p>
                  </caption>
                  <graphic xlink:href="pone.0252271.g006" position="float"/>
                </fig>
                <p>For the 90% of the population in lockdown in Spain, the basic reproduction number <italic toggle="yes">R</italic><sub>0</sub> = 8.0 decreased to <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 0.771 and <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 5.14, respectively, in circulating and lockdown populations on March 16. During a short period of transition from natural to lockdown epidemic, the high effective reproduction number in the isolated population resulted in a high number of infections (see C.7(b) Fig in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, practically all cases are originated in lockdown population), which postpone the peak of the daily CoViD-19 cases to March 27. On March 24, when the effectiveness of lockdown is observed, another reduction in the effective reproduction number occurs to <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 0.382 and <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 0.59, respectively, in circulating and lockdown populations. Although <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> &lt; 1, the number of new cases of CoViD-19 does not decrease quickly due to the high number of susceptible individuals. Hence, Spain’s example demonstrated that it is not enough to decrease the effective reproduction number below unity if the numbers of susceptible and infectious individuals are higher. On May 4 (phase 0 of release in Spain [<xref rid="pone.0252271.ref021" ref-type="bibr">21</xref>]) and June 8 (phase 3 of release) the effective reproduction number assumes, respectively, 0.53 and 0.51.</p>
                <p><xref rid="pone.0252271.g007" ref-type="fig">Fig 7</xref> shows the curve Ω<sub><italic toggle="yes">d</italic></sub> derived from Ω and the observed data in Spain (a), and the estimated curve of Ω with observed data, the curves <italic toggle="yes">D</italic><sub>2</sub> and Ω<sub><italic toggle="yes">d</italic></sub> with the observed data (b).</p>
                <fig position="float" id="pone.0252271.g007">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0252271.g007</object-id>
                  <label>Fig 7</label>
                  <caption>
                    <p>The calculated curve Ω<sub><italic toggle="yes">d</italic></sub> and the observed daily cases in Spain (a), and the initial part of the estimated curve Ω with observed data Ω<sup><italic toggle="yes">ob</italic></sup>, the extended Ω<sub><italic toggle="yes">d</italic></sub> and daily observed cases <inline-formula id="pone.0252271.e042"><alternatives><graphic xlink:href="pone.0252271.e042" id="pone.0252271.e042g" position="anchor"/><mml:math id="M42" display="inline" overflow="scroll"><mml:msubsup><mml:mo>Ω</mml:mo><mml:mi>d</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>, and severe covid-19 cases <italic toggle="yes">D</italic><sub>2</sub> (b). All curves are the sum of the cases in circulating and locked-down populations.</p>
                  </caption>
                  <graphic xlink:href="pone.0252271.g007" position="float"/>
                </fig>
                <p>The peaks of the estimated curves Ω<sub><italic toggle="yes">d</italic></sub> and <italic toggle="yes">D</italic><sub>2</sub> are, respectively, 8, 922 and 80, 750, which occur on March 27 and April 6. The estimated daily cases’ peak occurred one day later than the observed daily cases’ peak, 9, 177 on March 26. However, for <italic toggle="yes">k</italic> = 0.8, the peaks of the estimated curves Ω<sub><italic toggle="yes">d</italic></sub> and <italic toggle="yes">D</italic><sub>2</sub> are, respectively, 9, 566 and 80, 020 occurring on March 28 and April 6. The value of the peak of the estimated daily cases and the date it occurred show that 90% of the population in lockdown explains better the daily observed data in Spain than 80%.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec006">
              <title>Discussion</title>
              <p>Firstly, we compare the epidemiological scenarios of the isolation in São Paulo State and the lockdown in Spain. Secondly, we address the critical question of the reliable estimation for <italic toggle="yes">R</italic><sub>0</sub>. Finally, we discuss the model proposed here.</p>
              <sec id="sec007">
                <title>Comparing CoViD-19 epidemic in São Paulo State and Spain</title>
                <p>To evaluate two different approaches to control the CoViD-19 epidemic, we considered two regions with similar population sizes—Spain (47.4 million, lockdown) and São Paulo State (44.6 million, partial quarantine). Spain has 6% more inhabitants than São Paulo State and implemented the lockdown 45 days after the first case of CoVid-19, 18 days later than the isolation implemented in São Paulo State after the first case. Spain has 48% less demographic density and 41% more proportion of elders than São Paulo State.</p>
                <p>The widespread epidemic of CoViD-19 led Spain to implement lockdown, and the number of asymptomatic persons was higher as shown in Eq (C.2) in Section C of <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, while in São Paulo State, the population was isolated earlier, for this reason, the number of asymptomatic persons was not so high as shown in Eq (C.1) in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>. In the population in lockdown in Spain, the numbers of infectious and susceptible persons are, respectively, 3 and 1.8 times more than those found in isolation in São Paulo State. The number of new infection cases is proportional to the product of the numbers of infectious and susceptible persons; hence the population in lockdown in Spain has 5.4 times more risk of an outbreak of the epidemic than in São Paulo State. Thus, we neglected the SARS-CoV-2 transmission in the isolated population in São Paulo State; however, to explain Spain’s observed data, we allowed a low transmission (through restricted contact occurring in the household and neighborhood) in the lockdown population. Indeed, the model provided that almost all severe CoViD-19 cases originated from the lockdown population in Spain, although <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 0.59. However, the epidemic of CoViD-19 in São Paulo State occurred in the circulating population, with the effective reproduction number jumping down to <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 4.35 when the isolation in 53% of the population was implemented on March 24, which decreased more to <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 2.1 with the adoption of protective measures on April 4. According to the definition in [<xref rid="pone.0252271.ref007" ref-type="bibr">7</xref>], São Paulo State is an example of mitigation, while Spain, of suppression.</p>
                <p>The value of <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub>, from the beginning of the epidemic to the implementation of lockdown/isolation, decreased by 0.29 (with 8, 122 cases of severe CoViD-19) and 0.02 (with 397 cases), respectively, in Spain and São Paulo State. Moreover, the peak of severe CoViD-19 cases occurred on April 6 (66 days after the beginning of the epidemic), with 80, 750 cases in Spain, which is 17% of 474, 900 cases in the natural epidemic. In São Paulo State, the estimated peak of severe cases will occur on June 23 (118 days after the beginning of the epidemic) with 67, 140 cases (83% of Spain), 18% of 386, 400 cases in the natural epidemic. The 52 days gained by São Paulo State are precious to avoid overloading the health system, showing that the early adoption of isolation or lockdown is crucial to control the epidemic.</p>
                <p>The estimated <italic toggle="yes">R</italic><sub>0</sub> for CoViD-19 in Spain is 87% of that in São Paulo State, although the peak and the accumulated cases at the end of the first wave of the natural epidemic are 123% and 124% of those found in São Paulo State. We can understand this finding by analyzing the partial reproduction numbers <italic toggle="yes">R</italic><sub>0<italic toggle="yes">y</italic></sub> for young and <italic toggle="yes">R</italic><sub>0<italic toggle="yes">o</italic></sub> for elder subpopulations. For São Paulo State, we estimated <italic toggle="yes">R</italic><sub>0<italic toggle="yes">y</italic></sub> = 7.73 and <italic toggle="yes">R</italic><sub>0<italic toggle="yes">o</italic></sub> = 1.51. From the model, the fractions of young and elder susceptible persons reach, in the long-term epidemic, respectively, <inline-formula id="pone.0252271.e043"><alternatives><graphic xlink:href="pone.0252271.e043.jpg" id="pone.0252271.e043g" position="anchor"/><mml:math id="M43" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>s</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>*</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.13</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e044"><alternatives><graphic xlink:href="pone.0252271.e044.jpg" id="pone.0252271.e044g" position="anchor"/><mml:math id="M44" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>*</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.66</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. However, when young and elder subpopulations are not separated but are interacting in the circulating population, we obtained <inline-formula id="pone.0252271.e045"><alternatives><graphic xlink:href="pone.0252271.e045.jpg" id="pone.0252271.e045g" position="anchor"/><mml:math id="M45" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>s</mml:mi><mml:mi>y</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.1034</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0252271.e046"><alternatives><graphic xlink:href="pone.0252271.e046.jpg" id="pone.0252271.e046g" position="anchor"/><mml:math id="M46" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.0017</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. Notice that the difference <inline-formula id="pone.0252271.e047"><alternatives><graphic xlink:href="pone.0252271.e047.jpg" id="pone.0252271.e047g" position="anchor"/><mml:math id="M47" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>s</mml:mi><mml:mi>j</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>*</mml:mo></mml:mrow></mml:msubsup><mml:mo>−</mml:mo><mml:msubsup><mml:mi>s</mml:mi><mml:mi>j</mml:mi><mml:mo>*</mml:mo></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>, <italic toggle="yes">j</italic> = <italic toggle="yes">y</italic>, <italic toggle="yes">o</italic>, is the additional proportion of susceptible persons infected due to interaction, being 2.7% for young and 66% for elder persons, showing that elder persons are 24 times more risk than young persons when they interact. For Spain, we estimated <italic toggle="yes">R</italic><sub>0<italic toggle="yes">y</italic></sub> = 5.81 and <italic toggle="yes">R</italic><sub>0<italic toggle="yes">o</italic></sub> = 2.19, which are 75% and 145% of those estimated in São Paulo State. For the number of accumulated cases, Spain has 93% (young) and 179% (elder) of severe CoViD-19 cases of those found in São Paulo State. For the number of cases at the peak of the epidemic, Spain has 90% (young) and 168% (elder) of those found in São Paulo State. Finally, in Spain, the most infections occurred in 90% of the lockdown population, with 25.8% being composed of the elder persons, while in São Paulo State, the infections were occurring in 47% of the circulating population with 15.3% being composed of the elder persons. Therefore, the higher number of cases with lower <italic toggle="yes">R</italic><sub>0</sub> in Spain can be explained epidemiologically by lockdown, which allowed a higher number of elder persons in close contact with young persons, increasing the infection in the vulnerable elder subpopulation.</p>
                <p>At the end of the first wave of the epidemic in quarantine, the accumulated severe CoViD-19 cases in Spain are 320, 200, and in São Paulo State, 386, 600 (121% of the cases in Spain), although the peak of the epidemic in Spain is higher. As a consequence, the lockdown implemented in Spain reduced the number of CoViD-19 cases (27% of the natural epidemic) more than isolation adopted in São Paulo State (41% of the natural epidemic), which impacts the number of immune (recovered) persons. The number of young and elder immune persons are, respectively, 15.14 million (99%) and 2.82 million (97%) for São Paulo State, and 9.13 million (99%) and 3.41 million (98%) for Spain. The percentage between parentheses is the ratio between the numbers of immune persons and new cases of CoViD-19 <italic toggle="yes">I</italic>/Φ. In São Paulo State, the total number of immune persons at the end of the first wave of the epidemic is 40% of the population, while in Spain, 26.5%. On June 15 (beginning of release), the proportion of the São Paulo State’s immune person is 16.7%. In Spain, on May 4 (phase 0 of release), June 8 (phase 3 of release), and 15, the proportions of the immune persons are, respectively, 18%, 23.5%, and 24.4%, showing that on June 8, Spain is close to the end of the first wave of the epidemic. However, if lockdown/isolation and protective measures are relaxed or abandoned, Spain and São Paulo State will be at higher risk to trigger a second wave of the epidemic due to an increased number of susceptible persons and a low number of immune persons at the end of the first wave of the epidemic.</p>
                <p>At the end of the first wave of the epidemic in quarantine, the estimated number of deaths in Spain is 32, 150 (10% of all cases), while in São Paulo State is 23, 780 (6% of all cases), which is 74% of the total deaths in Spain. The São Paulo State’s severity case fatality rate is 3.7 times higher in young and 1.4 times lower in the elder than in Spain (see Section C in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>). Both severity cases and infection fatality rates for Spain for young and elder persons are around 30% and 138% of the São Paulo State rates. These rates in elder subpopulation could be explained by the life expectancy (São Paulo State has 78.4 <italic toggle="yes">years</italic> and Spain, 83.4 <italic toggle="yes">years</italic>), because 59.7% of deaths occurred in elder persons with 80 years old or more in Spain [<xref rid="pone.0252271.ref020" ref-type="bibr">20</xref>]. However, a higher proportion of uncontrolled comorbidity in the young subpopulation in São Paulo State increased the number of deaths [<xref rid="pone.0252271.ref022" ref-type="bibr">22</xref>].</p>
                <p>The number of deaths was around 12% of severe CoViD-19 cases in Spain, while in São Paulo State, it was about 7% on May 20. The number of deaths is closely related to the number of severe CoViD-19 cases. As we pointed out, the close interaction between lockdown young and elder subpopulations (the presence of infectious young individuals increases the risk of infection among elders [<xref rid="pone.0252271.ref023" ref-type="bibr">23</xref>]) increased the epidemic in the elder subpopulation, increasing deaths. Moreover, the quick increase in the number of severe CoViD-19 in Spain overloaded hospitals and contributed to a rise in untreated patients’ death, especially elders. The current relatively low number of fatalities in São Paulo State compared with that observed in Spain indicate that the health care system must be prepared to avoid hospital overload.</p>
                <p>The daily registered CoViD-19 cases in B.1(a) and B.3(a) in Section B of <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref> showed an increasing phase (<italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> &gt; 1) followed by a decreasing phase (<italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> &lt; 1) after reaching a maximum value at around <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 1. The accumulated CoViD-19 cases shown in B.1(b) and B.3(b) Figs in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, however, showed a sigmoid shape curve, that is, a quick increase in the first phase (<italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> &gt; 1, upward concavity) followed by a slow increase phase (<italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> &lt; 1, downward concavity) of the epidemic. When the daily cases attain their maximum value (<italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 1), the sigmoid curve changes the concavity, called the inflection point (or time). This shape can be used in connection with the efforts to eradicate an infection (vaccination or quarantine), which must be equal or greater than <italic toggle="yes">f</italic><sub>min</sub> = 1 − 1/<italic toggle="yes">R</italic><sub>0</sub>, the threshold of the fraction of susceptible individuals [<xref rid="pone.0252271.ref010" ref-type="bibr">10</xref>].</p>
                <p>The curve of the accumulated CoViD-19 Ω and the observed data in Spain (C.7(b) and B.3(b) Figs in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>) showed the inflection point 11 days after the implementation of lockdown. It means that the lockdown resulted in <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 1 soon. Letting <italic toggle="yes">f</italic><sub>min</sub> = 0.7, we must have <italic toggle="yes">R</italic><sub>0</sub> &gt; 3.3 to describe the observed epidemic after lockdown, but for <italic toggle="yes">f</italic><sub>min</sub> = 0.8, we must have <italic toggle="yes">R</italic><sub>0</sub> &gt; 5. However, the curve of Ω and observed data after the adoption of isolation in São Paulo State showed upward concavity after isolating 53% of individuals, and they reached the inflection point 80 days later (as we pointed out, <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 2.1 on March 24.) Suppose that <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 1 with 53%, hence, letting <italic toggle="yes">f</italic><sub>min</sub> = 0.53, we must have <italic toggle="yes">R</italic><sub>0</sub> &gt; 2.1 to describe the observed epidemic after isolation. However, the long period to reach the inflection point demonstrates that <italic toggle="yes">R</italic><sub>0</sub> must be much higher than 2.1.</p>
              </sec>
              <sec id="sec008">
                <title>Reliable estimation of <italic toggle="yes">R</italic><sub>0</sub></title>
                <p>Amer <italic toggle="yes">et al</italic>. [<xref rid="pone.0252271.ref012" ref-type="bibr">12</xref>] developed the IPR (Infected Patient Ratio) tool to measure the number of patients resulting from 1 primary infector during the incubation period. Using historical data from Italy, Germany, Spain, France, the United States of America, and China, they calculated a median of 16 patients infected by a primary infector during the incubation period. Accepting that the basic reproduction number <italic toggle="yes">R</italic><sub>0</sub> is roughly associated with IPR, the estimated <italic toggle="yes">R</italic><sub>0</sub> for São Paulo State (9.24) and Spain (8.0) are closer to the calculated IPR than estimations around 3. Moreover, Amer <italic toggle="yes">et al</italic>. observed in China that the average IPR dropped from 38 infected patients to 4 after only 12 days of lockdown (decreased by 89.5%). On the other hand, on March 28, 12 days after the lockdown in Spain, the effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> was around 0.6, decreasing by 92.5%. Performing statistical analysis (segmented regressions), Santamaría and Hortal [<xref rid="pone.0252271.ref013" ref-type="bibr">13</xref>] described the effectiveness of lockdown in Spain associated with protective measures.</p>
                <p>In the literature, the usually assumed basic reproduction number <italic toggle="yes">R</italic><sub>0</sub> is around 2−3, see for instance [<xref rid="pone.0252271.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0252271.ref007" ref-type="bibr">7</xref>]. However, Li <italic toggle="yes">et al</italic>. [<xref rid="pone.0252271.ref008" ref-type="bibr">8</xref>] explicitly cited that, by using data from January 10 to February 8, 2020, they estimated the effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub>, arguing that the most recent common ancestor could have occurred on November 17, 2019. The time elapsed from November 17, 2019 (the first case) to January 10, 2020 (the first day in the estimation) is 54 days. On January 23, 2020, Wuhan and other cities of Hubei province imposed a lockdown. As we pointed out in C.1(b) Fig in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, taking into account the entire data or restricting the interval of data around quarantine implementation, the estimated <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> must be lower.</p>
                <p>From Figs <xref rid="pone.0252271.g003" ref-type="fig">3</xref> and <xref rid="pone.0252271.g006" ref-type="fig">6</xref>, the effective reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> for São Paulo State, 54 days after the beginning of the epidemic, is 2.1 (April 20), while for Spain, <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> = 0.6 (March 25). In other words, using CoViD-19 data beginning from April 20 (São Paulo State) or March 25 (Spain), probably the estimated effective reproduction number will be close to those retrieved from Figs <xref rid="pone.0252271.g003" ref-type="fig">3</xref> and <xref rid="pone.0252271.g006" ref-type="fig">6</xref>. On the other hand, if we estimate the basic reproduction number using the SIR model with different infective persons at <italic toggle="yes">t</italic> = 0, we obtained, using data collected from São Paulo State, <italic toggle="yes">R</italic><sub>0</sub> = 3.22 (for <italic toggle="yes">I</italic>(0) = 10), or <italic toggle="yes">R</italic><sub>0</sub> = 2.66 (for <italic toggle="yes">I</italic>(0) = 25), or <italic toggle="yes">R</italic><sub>0</sub> = 2.38 (for <italic toggle="yes">I</italic>(0) = 50), with other initial conditions being <italic toggle="yes">S</italic>(0) = 44.6 million, and <italic toggle="yes">R</italic>(0) = 0. The SIR model is formulated considering only one class of infectious individuals. However, the available data at the beginning of the epidemic is the severe CoViD-19 cases, which are hospitalized and, probably, they are not transmitting except to the hospital staff. Hence, the SEIR model is not appropriate to describe the CoViD-19 epidemic [<xref rid="pone.0252271.ref009" ref-type="bibr">9</xref>].</p>
                <p>The reliable estimation of <italic toggle="yes">R</italic><sub>0</sub> is essential because this number determines the magnitude of effort to eradicate infection. In the case of vaccination, the efforts to eradicate a disease must be vaccinating a fraction equal to or greater than 1 − 1/<italic toggle="yes">R</italic><sub>0</sub> of susceptible individuals [<xref rid="pone.0252271.ref010" ref-type="bibr">10</xref>]. In Yang [<xref rid="pone.0252271.ref024" ref-type="bibr">24</xref>], analyzing vaccination as a control mechanism, if <italic toggle="yes">R</italic><sub>0</sub> is reduced by the vaccine to a value lower than one, the number of cases decreased following exponential-type decay, as we observed in <xref rid="pone.0252271.g006" ref-type="fig">Fig 6</xref> describing the lockdown in Spain. Hence, instead of a vaccine, let us consider lockdown to control CoViD-19 transmission. If <italic toggle="yes">R</italic><sub>0</sub> = 3, we must isolate at least 67% of the population, while for <italic toggle="yes">R</italic><sub>0</sub> = 8, at least 87% of the population. As we have pointed out, 70% of the people in lockdown did not explain the CoViD-19 data in Spain, but 90% of the people in lockdown described better the observed data. Hence, our estimation of <italic toggle="yes">R</italic><sub>0</sub> for Spain using the first period of CoViD-19 data is more reliable than that provided by the SEIR model.</p>
                <p>In Yang <italic toggle="yes">et al</italic>. [<xref rid="pone.0252271.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0252271.ref025" ref-type="bibr">25</xref>], we estimated the additional mortality rates based on the observed data and concluded that their values fitted well at the beginning of the epidemic but did not provide reliable fitting in the long-term epidemic. For instance, that method of estimation pairing the numbers of new cases and deaths at the registering time resulted in deaths of 30% up to 80% of severe CoViD-19 cases at the end of the epidemic’s first wave. For this reason, we had adopted a second method of estimation considering that the accumulated deaths in the elder subpopulation at the end of the first wave of the epidemic must be around 10%, underestimating the number of deaths at the beginning of the epidemic. Here, we improved the estimation of the additional mortality rates by pairing the numbers of new cases and deaths not at the registering time but delayed in 15 days, which is suggested by comparing the daily registered data of new cases with fatalities (see B.1 Fig in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>). C.4 and C.8 Figs in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref> showed that this novel method of estimation fits relatively well during the three periods of the epidemic with Δ = 15 <italic toggle="yes">days</italic>. However, we can vary Δ according to the period of the epidemic to obtain a better fitting. For instance, in C.8 Fig in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, the accumulated data of deaths corresponding to the natural epidemic is well fitted using Δ = 7 <italic toggle="yes">days</italic>.</p>
                <p>The concept of herd immunity is associated with the protection provided by immunized persons to a specific subpopulation under a higher risk of death caused by a syndrome or comorbidity. For instance, in the rubella infection, mass vaccination was planned to diminish the infection among pregnant women to reduce the number of congenital rubella syndrome [<xref rid="pone.0252271.ref026" ref-type="bibr">26</xref>]. The vaccination jumps down <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> as shown in Figs <xref rid="pone.0252271.g003" ref-type="fig">3</xref> and <xref rid="pone.0252271.g006" ref-type="fig">6</xref>, and the isolation of a fraction <italic toggle="yes">k</italic> of the susceptible persons. Different from the permanent reduction promoted by a vaccine, the herd protection implemented in a population reduces <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> temporarily and lasts whenever the population maintains adherence to lockdown/isolation and protective measures. Hence, the non-pharmaceutical interventions protect especially the elder subpopulation under higher risk of infection and death.</p>
              </sec>
              <sec id="sec009">
                <title>Notes regarding the model</title>
                <p>We formulated a deterministic compartment model to describe the quarantine as a control mechanism of the CoViD-19 epidemic. The model considered essential compartments according to the natural history of CoVid-19, and the depending on age fatality was incorporated considering two subpopulations. This model is minimalist also in retrieving the basic reproduction number <italic toggle="yes">R</italic><sub>0</sub> analytically: Any addition in compartments and or age groups becomes this task extremely hard or impossible.</p>
                <p>The model considered homogeneity in the spatial distribution, social contact and behavior, genetic, nutrition, etc. In Section A.4 in <xref rid="pone.0252271.s001" ref-type="supplementary-material">S1 Appendix</xref>, we present different mathematical approaches to incorporate some elements of heterogeneity. The model did not take into account the loss of immunity neither the reinfection. SARS-CoV-2, like all RNA-based viruses, mutates faster and may originate variants of the original virus, which was not considered in the model.</p>
                <p>We applied the model to describe the data recorded from São Paulo State and Spain. The vital dynamic and natural history of CoViD-19 parameters’ values in <xref rid="pone.0252271.t002" ref-type="table">Table 2</xref> can be evaluated for other countries or regions. Using these values, the SARS-CoV-2 transmission and intervention parameters can be fitted against the observed CoViD-19 data. The further observed severe CoViD-19 cases and deaths must be confronted with the model’s predictions while the interventions last. Once the model’s predictability was verified, the epidemiological scenario of the isolation can be considered as the background to evaluate (or predict the outcomes of) the relaxation strategies.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec010">
              <title>Conclusion</title>
              <p>In the absence of effective treatment and vaccine, the lockdown adoption at the very beginning of the epidemic is recommended to control the SARS-CoV-2 with high transmissibility and lethality. The second strategy is the implementation of isolating, as São Paulo State did. In this strategy, the epidemic curve of CoViD-19 in the circulating population is flattened to avoid the overloading in hospitals, and the immunization by the natural epidemic is increased—unfortunately, the number of deaths due to CoViD-19 increases. The third strategy, the adoption of lockdown, is recommended when the epidemic is out of control, and Spain is an example. In the second and third strategies to control the CoViD-19 epidemic, the severe CoViD-19 data before the adoption of isolation or lockdown are used to estimate the basic reproduction number.</p>
              <p>Quarantine (isolation and lockdown) is a valuable measure to control an epidemic with high lethality. Due to the health care system’s critical situation, Spain imposed a rigid quarantine (lockdown), which impacted the fast ascending phase of the epidemic by reducing <italic toggle="yes">R</italic><sub><italic toggle="yes">ef</italic></sub> below one. This reduction resulted in a peak of 80, 750 cases occurring 20 days after the implementation of lockdown (on March 16, Ω<sup><italic toggle="yes">ob</italic></sup> = 14, 011). Convinced by the epidemiological situation in Spain, São Paulo State implemented partial quarantine (isolation) and, as a result, the peak of 67, 140 cases will occur 91 days after the isolation (on March 24, Ω<sup><italic toggle="yes">ob</italic></sup> = 810). The relatively early implementation of the isolation in São Paulo State somehow avoided the overloading in the health care system by flattening the epidemic curve.</p>
              <p>The proportion of the immune (recovered) persons at the end of the first wave of epidemic is 40% of São Paulo State’s population and 26% of Spain’s population. On June 8 (phase 3 of the release in Spain [<xref rid="pone.0252271.ref021" ref-type="bibr">21</xref>]), the effective reproduction number was 0.51, and 23.5% of the population was immune, showing that Spain was close to the end of the first wave of the epidemic. This relatively safe epidemiological scenario was favorable to implement a carefully planned relaxation (release). However, on June 15, the effective reproduction number was 0.98, but in the ascending phase of the epidemic, and 16.7% of the population was immune, showing that São Paulo State was far from the end of the epidemic. The release of the isolated persons in this unfavorable epidemiological scenario may enhance the already intense transmission of SARS-CoV-2. Additionally, the abandonment of protective measures (face mask, washing hands, and social distancing) may result in a fierce retaken of the epidemic, especially in Spain.</p>
            </sec>
            <sec id="sec011" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0252271.s001" position="float" content-type="local-data">
                <label>S1 Appendix</label>
                <caption>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0252271.s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We thank to anonymous referees for providing comments and suggestions, which contributed to improving this paper.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0252271.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>L</given-names></name>, <etal>et al</etal>. <source>Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals</source>. [published April 27, <year>2020</year>; accessed May 10, 2020] Available from: <pub-id pub-id-type="doi">10.1038/s41586-020-2271-3</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>A novel Coronavirus from patients with pneumonia in China, 2019</article-title>. <source>N. Eng. J. Med</source>. <year>2020</year>; <volume>381</volume>: <fpage>1</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref003">
                <label>3</label>
                <mixed-citation publication-type="other">WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (CoViD-19). 16-24 February 2020, 2020; pp 40.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Tian</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China</article-title>. <source>Science</source><year>2020</year>; <volume>368</volume> (<issue>6491</issue>): <fpage>638</fpage>–<lpage>642</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.abb6105</pub-id>
<?supplied-pmid 32234804?><pub-id pub-id-type="pmid">32234804</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Chu</surname><given-names>DK</given-names></name>, <etal>et al</etal>. <article-title>Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis</article-title>. <source>The Lancet</source><year>2020</year>; Published online June 1, 2020 <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31142-9</pub-id><?supplied-pmid 32497510?><pub-id pub-id-type="pmid">32497510</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Koo</surname><given-names>JR</given-names></name>, <etal>et al</etal>. <article-title>Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study</article-title>. <source>Lancet Infect Dis</source>. <year>2020</year>; <volume>20</volume> (<issue>6</issue>): <fpage>678</fpage>–<lpage>688</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30162-6</pub-id>
<?supplied-pmid 32213332?><pub-id pub-id-type="pmid">32213332</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Ferguson</surname><given-names>NM</given-names></name>, <etal>et al</etal>. <article-title>Impact of non-pharmaceutical interventions (NPIs) to reduce CoViD-19 mortality and healthcare demand</article-title>. <source>Imperial College CoViD-19 Response Team</source><volume>2020</volume>; <month>March</month><day>16</day>, <year>2020</year>. <pub-id pub-id-type="doi">10.25561/77482</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>RY</given-names></name>, <etal>et al</etal>. <article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)</article-title>. <source>Science</source><year>2020</year>; <volume>368</volume>(<issue>6490</issue>): <fpage>489</fpage>–<lpage>493</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.abb3221</pub-id>
<?supplied-pmid 32179701?><pub-id pub-id-type="pmid">32179701</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref009">
                <label>9</label>
                <mixed-citation publication-type="other">Yang HM, Lombardi Junior LP, Campos AC. Are the SIR and SEIR models suitable to estimate the basic reproduction number for the CoViD-19 epidemic? MedRxiv [Preprint]. 2020 medRxiv 20210831 [posted October 20, 2020; revised December 28, 2020; accessed May 5, 2021]: [31 p.]. Available from: <pub-id pub-id-type="doi">10.1101/2020.10.11.20210831</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref010">
                <label>10</label>
                <mixed-citation publication-type="book"><name><surname>Anderson</surname><given-names>RM</given-names></name>, <name><surname>May</surname><given-names>RM</given-names></name>. <chapter-title>Infectious Diseases of Human</chapter-title>. <source>Dynamics and Control</source>. <publisher-loc>Oxford, New York, Tokyo</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>1991</year>: <fpage>757</fpage> p.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>HM</given-names></name>, <name><surname>Lombardi Junior</surname><given-names>LP</given-names></name>, <name><surname>Castro</surname><given-names>FFM</given-names></name>, <name><surname>Campos</surname><given-names>AC</given-names></name>. <article-title>Mathematical model describing CoViD-19 in São Paulo State, Brazil—Evaluating isolation as control mechanism and forecasting epidemiological scenarios of release</article-title>. <source>Epidemiology and Infection</source><year>2020</year>; <volume>148</volume>: <fpage>e155</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/S0950268820001600</pub-id><?supplied-pmid 32684175?><pub-id pub-id-type="pmid">32684175</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Amer</surname><given-names>F</given-names></name>, <name><surname>Hammoud</surname><given-names>S</given-names></name>, <name><surname>Farran</surname><given-names>B</given-names></name>, <name><surname>Boncz</surname><given-names>I</given-names></name>, <name><surname>Endrei</surname><given-names>D</given-names></name>. <article-title>Assessment of countries’ preparedness and lockdown effectiveness in fighting COVID-19</article-title>. <source>Disaster Medicine and Public Health Preparedness</source><year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/dmp.2020.217</pub-id><?supplied-pmid 32576332?><pub-id pub-id-type="pmid">32576332</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Santamaría</surname><given-names>L</given-names></name>, <name><surname>Hortal</surname><given-names>J</given-names></name>. <article-title>Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain</article-title>. <source>Epidemiology and Infection</source><year>2020</year>; <volume>148</volume>: <fpage>e282</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/S0950268820002782</pub-id><?supplied-pmid 33183397?><pub-id pub-id-type="pmid">33183397</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Guirao</surname><given-names>A</given-names></name>. <article-title>The Covid-19 outbreak in Spain. A simple dynamics model, some lessons, and a theoretical framework for control response</article-title>. <source>Infectious Disease Modelling</source><year>2020</year>; <volume>5</volume>: <fpage>652</fpage>–<lpage>669</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.idm.2020.08.010</pub-id>
<?supplied-pmid 32869008?><pub-id pub-id-type="pmid">32869008</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref015">
                <label>15</label>
                <mixed-citation publication-type="book"><name><surname>Battineni</surname><given-names>G</given-names></name>, <name><surname>Chintalapudi</surname><given-names>N</given-names></name>, <name><surname>Amenta</surname><given-names>F</given-names></name>. (<year>2020</year>), <chapter-title>SARS-CoV-2 epidemic calculation in Italy by SEIR compartmental models</chapter-title>. <source>Applied Computing and Informatics</source> 2020; <publisher-name>Emerald Publishing Limited</publisher-name>: <volume>11</volume> pg. <pub-id pub-id-type="doi">10.1108/ACI-09-2020-0060</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref016">
                <label>16</label>
                <mixed-citation publication-type="other">SEADE—Fundação Sistema Estadual; 2020 [accessed April 20, 2020]. Database [Internet]. Available from: <ext-link xlink:href="https://www.seade.gov.br" ext-link-type="uri">https://www.seade.gov.br</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref017">
                <label>17</label>
                <mixed-citation publication-type="other">PopulatioPyramid.net; 2020 [accessed April 30, 2020]. Database [Internet]. Available from: <ext-link xlink:href="https://www.populationpyramid.net/" ext-link-type="uri">https://www.populationpyramid.net/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref018">
                <label>18</label>
                <mixed-citation publication-type="other">Yang HM. Are the beginning and ending phases of epidemics provided by next generation matrices?—Revisiting drug sensitive and resistant tuberculosis model. arXiv: 2006.06857 [Preprint]. 2020 [submitted June 11, 2020; accessed June 11, 2020]. Available from: <ext-link xlink:href="http://arxiv.org/abs/2006.06857" ext-link-type="uri">http://arxiv.org/abs/2006.06857</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref019">
                <label>19</label>
                <mixed-citation publication-type="other">Instituto Nacional de Estadística; 2020 [accessed May 22, 2020]. Database INE [Internet]. Available from: <ext-link xlink:href="https://www.ine.es/en/index.htm" ext-link-type="uri">https://www.ine.es/en/index.htm</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref020">
                <label>20</label>
                <mixed-citation publication-type="other">Covid-19: death toll by age groups in Brazil, Italy, Spain and the US; 2020 [accessed May 22, 2020]. Datbase PODER360 [Internet]. Available from: <ext-link xlink:href="https://www.poder360.com.br/coronavirus/CoViD-19-death-toll-by-age-groups-in-brazil-italy-spain-the-us/" ext-link-type="uri">https://www.poder360.com.br/coronavirus/CoViD-19-death-toll-by-age-groups-in-brazil-italy-spain-the-us/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref021">
                <label>21</label>
                <mixed-citation publication-type="other">Plan para la Transición hacia una nueva normalidad; 2020 [accessed May 25, 2020]. Database [Internet]. Avaialble from: <ext-link xlink:href="https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/planDesescalada.htm" ext-link-type="uri">https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/planDesescalada.htm</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Rezende</surname><given-names>LFM</given-names></name>, <name><surname>Thome</surname><given-names>B</given-names></name>, <name><surname>Schveitzer</surname><given-names>MC</given-names></name>, <name><surname>Souza-Júnior PRB; Szwarcwald</surname><given-names>CL</given-names></name>. <article-title>Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil</article-title>. <source>Rev. Saúde Pública</source><year>2020</year>; <volume>54</volume>: Epub 15-May-2020. <comment>doi: </comment><pub-id pub-id-type="doi">10.11606/s1518-8787.2020054002596</pub-id><?supplied-pmid 32491091?><pub-id pub-id-type="pmid">32491091</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref023">
                <label>23</label>
                <mixed-citation publication-type="other">Yang HM, Lombardi Junior LP, Castro FFM, Campos AC. Evaluating reduction in CoViD-19 cases by isolation and protective measures in São Paulo State, Brazil, and scenarios of release. MedRxiv [Preprint]. 2020 medRxiv 20099309v2 [posted May 22, 2020; revised June 4, 2020; accessed June 5, 2020]: [55 p.]. Available from: <ext-link xlink:href="https://www.medrxiv.org/content/10.1101/2020.05.19.20099309v2" ext-link-type="uri">https://www.medrxiv.org/content/10.1101/2020.05.19.20099309v2</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>HM</given-names></name>. <article-title>Modeling directly transmitted infections in a routinely vaccinated population—The force of infection described by Volterra integral equation</article-title>. <source>Applied Mathematics and Computation</source><year>2001</year>; <volume>122</volume> (<issue>1</issue>): <fpage>27</fpage>–<lpage>58</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0096-3003(00)00011-4</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0252271.ref025">
                <label>25</label>
                <mixed-citation publication-type="other">Yang HM, Lombardi Junior LP, Campos AC. Modeling the transmission of new coronavirus in the São Paulo State, Brazil—Assessing epidemiological impacts of isolating young and elder persons. arXiv: 2004.05715 [Preprint]. 2020 [submitted April 12, 2020; accessed May 20, 2020]. Available from: <ext-link xlink:href="https://arxiv.org/abs/2004.05715" ext-link-type="uri">https://arxiv.org/abs/2004.05715</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0252271.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>HM</given-names></name>, <name><surname>Freitas</surname><given-names>ARR</given-names></name>. <article-title>Biological view of vaccination described by mathematical modellings: from rubella do dengue vaccines</article-title>. <source>Math. Biosc. Engin</source>. <year>2019</year>; <volume>16</volume> (<issue>5</issue>): <fpage>3195</fpage>–<lpage>3214</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3934/mbe.2019159</pub-id>
<?supplied-pmid 31499609?><pub-id pub-id-type="pmid">31499609</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
          <sub-article article-type="aggregated-review-documents" id="pone.0252271.r001" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r001</article-id>
              <title-group>
                <article-title>Decision Letter 0</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Khudyakov</surname>
                    <given-names>Yury E</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Yury E Khudyakov</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Yury E Khudyakov</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj001" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>0</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">30 Sep 2020</named-content>
              </p>
              <p>PONE-D-20-19611</p>
              <p>Mathematical modeling of the transmission of SARS-CoV-2 - Evaluating the impact of isolation in São Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of covid-19</p>
              <p>PLOS ONE</p>
              <p>Dear Dr. Yang,</p>
              <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected.</p>
              <p>Specifically:</p>
              <p>==============================</p>
              <p>Your manuscript was reviewed by one expert in the field who found many important technical issues in your submission and produced a very strong recommendation. The most concerning are comments on validity of your model and estimates of R0. Please carefully consider the attached comments which we hope will help you to improve your work.</p>
              <p>==============================</p>
              <p>I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision.</p>
              <p>Yours sincerely,</p>
              <p>Yury E Khudyakov, PhD</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>[Note: HTML markup is below. Please do not edit.]</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <bold>Comments to the Author</bold>
              </p>
              <p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
              <p>Reviewer #1: No</p>
              <p>**********</p>
              <p>2. Has the statistical analysis been performed appropriately and rigorously? </p>
              <p>Reviewer #1: No</p>
              <p>**********</p>
              <p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
              <p>Reviewer #1: No</p>
              <p>**********</p>
              <p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
              <p>Reviewer #1: No</p>
              <p>**********</p>
              <p>5. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
              <p>Reviewer #1: 1) It is too long. Could you compress the paper ?</p>
              <p>2) The estimated R0 seems to very large. The author(s) should carefully discuss it. At least, I understand that the author(s) did something wrong. I am wondering that it is reasonable to evaluate R0 at steady state. It might affect the severe upper bias in R0. At least, they have to discuss carefully about other estimated R0 in the same data. Or they have to provide the estimation results in other area and compare them. If the estimation result in other area by the author(s) will be consistently higher than the earlier studies, the author(s) methodology should be concluded to be bias in R0. These robustness check should be necessary.</p>
              <p>3) We need to confidence interval of the estimated parameter. If CI of R0 include two, it might not be statistically difference among the earlier study.</p>
              <p>4) I understand that the model in this paper was deterministic SIR model. If so, you mention it in Introduction and never mention about individual based model, which is not related this paper.</p>
              <p>5) If you adopt deterministic SIR model without CI, you have to explain carefully the reason why　do they adopt it. I think that it is not meaningless the estimation without CI.</p>
              <p>6) The estimation of R0 should be done using epidemic curve, which indicates number of patient at onset date. the author(s) might use the data of the number of reported patients in each day. If so, the authors should take delay to report from onset into the model.</p>
              <p>7) The author(s) assume rubella is airborne infection, but I do not agree with it. Measles or varicella are airborne infection.</p>
              <p>8) Is really protection measure with mask or handwashing reduce R ? I think that reduction in going out before lock down seems to be more important proved by the earlier paper.</p>
              <p>9) Why the author(s) ignore less susceptible in children though the model has birth rate ? I think less susceptible in children is the most important question to answer for control of COVID-19.</p>
              <p>10) I do not agree with high lethality in COVID-19 to achieve herd immunity. Because the severe patient do not contact anyone other than hospila staff and thus almost not infectiousness. If the author(s) do not think so, they have to provide careful discussion.</p>
              <p>11) How do you the effect of lock down ? Can SIR model express lock down even it is complete homogenous model ?</p>
              <p>minor points</p>
              <p>1) The author(s) use covid-19 instead of COVID-19.</p>
              <p>2) The author(s) should change new to novel.</p>
              <p>3) What mean "immune person" ?</p>
              <p>**********</p>
              <p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
              <p>Reviewer #1: No</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>- - - - -</p>
              <p>For journal use only: PONEDEC3</p>
            </body>
          </sub-article>
          <sub-article article-type="author-comment" id="pone.0252271.r002">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r002</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 0</article-title>
              </title-group>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj002" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">29 Oct 2020</named-content>
              </p>
              <p>See Referee1.pdf</p>
              <supplementary-material id="pone.0252271.s002" position="float" content-type="local-data">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">Referee1.pdf</named-content></p>
                </caption>
                <media xlink:href="pone.0252271.s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article article-type="aggregated-review-documents" id="pone.0252271.r003" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r003</article-id>
              <title-group>
                <article-title>Decision Letter 1</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cheong</surname>
                    <given-names>Siew Ann</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Siew Ann Cheong</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Siew Ann Cheong</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj003" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">29 Dec 2020</named-content>
              </p>
              <p>PONE-D-20-19611R1</p>
              <p>Mathematical modeling of the transmission of SARS-CoV-2 - Evaluating the impact of isolation in São Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of covid-19</p>
              <p>PLOS ONE</p>
              <p>Dear Dr. Yang,</p>
              <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
              <p>In particular, please respond to Reviewer 2's comment on your estimate of R0 = 8 being too large for COVID-19. Please also prepare a table of estimated parameters (with confidence intervals, if possible) of your model, in response to Reviewer 3's comment.</p>
              <p>Please submit your revised manuscript by Feb 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
              <p>Please include the following items when submitting your revised manuscript:</p>
              <p>
                <list list-type="bullet">
                  <list-item>
                    <p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p>
                  </list-item>
                  <list-item>
                    <p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p>
                  </list-item>
                  <list-item>
                    <p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p>
                  </list-item>
                </list>
              </p>
              <p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
              <p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link></p>
              <p>We look forward to receiving your revised manuscript.</p>
              <p>Kind regards,</p>
              <p>Siew Ann Cheong, Ph.D.</p>
              <p>Fernanda C. Dórea</p>
              <p>Academic Editors</p>
              <p>PLOS ONE</p>
              <p>Journal Requirements:</p>
              <p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
              <p><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and</p>
              <p>
                <ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
              </p>
              <p>2. We note that your manuscript is not formatted using one of PLOS ONE’s accepted file types. Please reattach your manuscript as one of the following file types: .doc, .docx, .rtf, or .tex (accompanied by a .pdf).</p>
              <p>If your submission was prepared in LaTex, please submit your manuscript file in PDF format and attach your .tex file as “other.”</p>
              <p>3. Thank you for updating your data availability statement. You note that your data are available within the Supporting Information files, but no such files have been included with your submission. At this time we ask that you please upload your minimal data set as a Supporting Information file, or to a public repository such as Figshare or Dryad.</p>
              <p>Please also ensure that when you upload your file you include separate captions for your supplementary files at the end of your manuscript.</p>
              <p>As soon as you confirm the location of the data underlying your findings, we will be able to proceed with the review of your submission.</p>
              <p>Additional Editor Comments (if provided):</p>
              <p>[Note: HTML markup is below. Please do not edit.]</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <bold>Comments to the Author</bold>
              </p>
              <p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.</p>
              <p>Reviewer #2: All comments have been addressed</p>
              <p>Reviewer #3: (No Response)</p>
              <p>**********</p>
              <p>2. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
              <p>Reviewer #2: Yes</p>
              <p>Reviewer #3: Partly</p>
              <p>**********</p>
              <p>3. Has the statistical analysis been performed appropriately and rigorously? </p>
              <p>Reviewer #2: Yes</p>
              <p>Reviewer #3: N/A</p>
              <p>**********</p>
              <p>4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
              <p>Reviewer #2: Yes</p>
              <p>Reviewer #3: Yes</p>
              <p>**********</p>
              <p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
              <p>Reviewer #2: Yes</p>
              <p>Reviewer #3: Yes</p>
              <p>**********</p>
              <p>6. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
              <p>Reviewer #2: Thank you for the opportunity in consideration of reviewing the given manuscript. The manuscript presenting the epidemic modelling of COVID-19 among individual state in Brail and Spain. The study outcomes providing promising view in understanding of mitigation measures in these two places. However, I want to make notice to authors some minor comments</p>
              <p>� Materials and methods section should after introduction</p>
              <p>� In Italy and Spain, because of continuous lockdown and self-isolation it was possible to control the pandemic severity. In Introduction I found an orphan statement “S~ao Paulo State, however, implemented a partial quarantine (isolation) in the population to avoid critical epidemiological scenarios that occurred in Spain and Italy” [1][2]. To in line with this statement authors are recommended to include a citation of recent studies on these nations such as</p>
              <p>1. Antonio Guirao, The Covid-19 outbreak in Spain. A simple dynamics model, some lessons, and a theoretical framework for control response, Infectious Disease Modelling, Volume 5, 2020, Pages 652-669, <ext-link xlink:href="https://doi.org/10.1016/j.idm.2020.08.010" ext-link-type="uri">https://doi.org/10.1016/j.idm.2020.08.010</ext-link>.</p>
              <p>2. Battineni, G., Chintalapudi, N. and Amenta, F. (2020), "SARS-CoV-2 epidemic calculation in Italy by SEIR compartmental models", Applied Computing and Informatics, <ext-link xlink:href="https://doi.org/10.1108/ACI-09-2020-0060" ext-link-type="uri">https://doi.org/10.1108/ACI-09-2020-0060</ext-link></p>
              <p>� From the model parameters, we obtained for the basic reproduction number R0 = 9:24 for S~ao Paulo State, and R0 = 8 for Spain.</p>
              <p>The R0 seems very high, could you check the bias in this finding? With this rate, almost everyone in the country has to be infected. The high hit epidemic place like Lombardy, Italy R0 has registered about 6.5. I am surprising that this is the first study that met COVID-19 R0≥8. I would like to request authors for cross checking. However, this sentence should be in results section.</p>
              <p>� Please mention the limitation of the proposed model at bottom of discussion part</p>
              <p>Reviewer #3: The paper deals with the issues on COVID-19 in Sao Paolo state and Spain. I have some comments on this.</p>
              <p>1. What is the rationale behind choosing one state in Brazil and Spain? Is there any similarity between these two regions (one state and one country) for which they might be comparable with respect to some features of COVID outbreak?</p>
              <p>2. The model is too complicated involving too many parameters. Parameters of such a model are very difficult to estimate, unless one has very accurate data on all compartments and also about the transition between two compartments. The authors should clarify this to increase its readability. Moreover, this model depends on too many parameters; a rigorous sensitivity analysis is required to study the effect of variation in the parameters.</p>
              <p>3. There are many parameters whose estimates are not available (indicated by ***). Without any clear idea the analysis would be incomplete. Also the authors should study the effect of these parameters.</p>
              <p>4. The paper is too large. A shortened version is welcome.</p>
              <p>I suggest a major revision in view of the above comments before reaching any decision regarding acceptance or rejection of this manuscript.</p>
              <p>**********</p>
              <p>7. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
              <p>Reviewer #2: No</p>
              <p>Reviewer #3: No</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
            </body>
          </sub-article>
          <sub-article article-type="author-comment" id="pone.0252271.r004">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r004</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 1</article-title>
              </title-group>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj004" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>2</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">11 Jan 2021</named-content>
              </p>
              <p>We uploaded three files: ResponsetoEditors.pdf, ResponsetoReferee2.pdf and ResponsetoReferee3.pdf.</p>
              <supplementary-material id="pone.0252271.s003" position="float" content-type="local-data">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">About_table_2.pdf</named-content></p>
                </caption>
                <media xlink:href="pone.0252271.s003.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article article-type="aggregated-review-documents" id="pone.0252271.r005" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r005</article-id>
              <title-group>
                <article-title>Decision Letter 2</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cheong</surname>
                    <given-names>Siew Ann</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Siew Ann Cheong</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Siew Ann Cheong</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj005" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>2</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">11 Mar 2021</named-content>
              </p>
              <p>PONE-D-20-19611R2</p>
              <p>Mathematical modeling of the transmission of SARS-CoV-2 - Evaluating the impact of isolation in São Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of covid-19</p>
              <p>PLOS ONE</p>
              <p>Dear Dr. Yang,</p>
              <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
              <p>In particular, please address all the concerns of Reviewer 3, on the estimation of model parameters, and either estimate the covariances between parameters, or justify why they should be treated as zero.</p>
              <p>Please submit your revised manuscript by Apr 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
              <p>Please include the following items when submitting your revised manuscript:</p>
              <p>
                <list list-type="bullet">
                  <list-item>
                    <p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p>
                  </list-item>
                  <list-item>
                    <p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p>
                  </list-item>
                  <list-item>
                    <p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p>
                  </list-item>
                </list>
              </p>
              <p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
              <p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link></p>
              <p>We look forward to receiving your revised manuscript.</p>
              <p>Kind regards,</p>
              <p>Siew Ann Cheong, Ph.D.</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Journal Requirements:</p>
              <p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
              <p>[Note: HTML markup is below. Please do not edit.]</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <bold>Comments to the Author</bold>
              </p>
              <p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.</p>
              <p>Reviewer #2: All comments have been addressed</p>
              <p>Reviewer #3: (No Response)</p>
              <p>**********</p>
              <p>2. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
              <p>Reviewer #2: Yes</p>
              <p>Reviewer #3: Partly</p>
              <p>**********</p>
              <p>3. Has the statistical analysis been performed appropriately and rigorously? </p>
              <p>Reviewer #2: Yes</p>
              <p>Reviewer #3: No</p>
              <p>**********</p>
              <p>4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
              <p>Reviewer #2: Yes</p>
              <p>Reviewer #3: Yes</p>
              <p>**********</p>
              <p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
              <p>Reviewer #2: Yes</p>
              <p>Reviewer #3: Yes</p>
              <p>**********</p>
              <p>6. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
              <p>Reviewer #2: Author sufficiantly addressed the raised comments. It is now ready to accept in the current format</p>
              <p>Reviewer #3: The authors tried to address the issues raised by the reviewers. However, to my understanding, not all issues are addressed directly and adequately. During the sensitivity analysis, they have assumed the covariances to be zero without explaining the rationale behind it. If the concept of considering covariances occurs, it indicates that the parameters are treated as random but in the entire analysis (mathematical and numerical) all parameters are treated as constants. Moreover the reason of considering one state in a South American country and one country in Europe is not clear. One could have considered many such pairs. There are also some unambiguity in parameter estimation especially R0. Moreover, although there is a sense of heterogeneity on the model, the authors did not explicitly (and mathematically) use this idea in the model evaluation and analysis.</p>
              <p>Based on my understanding, I recommend rejecting the paper.</p>
              <p>**********</p>
              <p>7. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
              <p>Reviewer #2: <bold>Yes: </bold>Dr. Gopi Battineni</p>
              <p>Reviewer #3: No</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
              <supplementary-material id="pone.0252271.s004" position="float" content-type="local-data">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">Report on the manuscript PONE-D-20-19611_R2.pdf</named-content></p>
                </caption>
                <media xlink:href="pone.0252271.s004.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article article-type="author-comment" id="pone.0252271.r006">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r006</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 2</article-title>
              </title-group>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj006" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>3</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">14 Mar 2021</named-content>
              </p>
              <p>Please, see editor.pdf, ResponsetoReviewer2.pdf and ResponsetoReviewer3.pdf.</p>
              <supplementary-material id="pone.0252271.s005" position="float" content-type="local-data">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">ResponsetoReviewer3.pdf</named-content></p>
                </caption>
                <media xlink:href="pone.0252271.s005.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article article-type="aggregated-review-documents" id="pone.0252271.r007" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r007</article-id>
              <title-group>
                <article-title>Decision Letter 3</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cheong</surname>
                    <given-names>Siew Ann</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Siew Ann Cheong</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Siew Ann Cheong</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj007" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>3</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">27 Apr 2021</named-content>
              </p>
              <p>PONE-D-20-19611R3</p>
              <p>Mathematical modeling of the transmission of SARS-CoV-2 - Evaluating the impact of isolation in São Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of covid-19</p>
              <p>PLOS ONE</p>
              <p>Dear Dr. Yang,</p>
              <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
              <p>Please address the comments provided by Reviewer 4. I expect that no further review will be necessary.</p>
              <p>Please submit your revised manuscript by Jun 11 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
              <p>Please include the following items when submitting your revised manuscript:</p>
              <p>
                <list list-type="bullet">
                  <list-item>
                    <p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p>
                  </list-item>
                  <list-item>
                    <p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p>
                  </list-item>
                  <list-item>
                    <p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p>
                  </list-item>
                </list>
              </p>
              <p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
              <p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p>
              <p>We look forward to receiving your revised manuscript.</p>
              <p>Kind regards,</p>
              <p>Siew Ann Cheong, Ph.D.</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Journal Requirements:</p>
              <p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
              <p>[Note: HTML markup is below. Please do not edit.]</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <bold>Comments to the Author</bold>
              </p>
              <p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.</p>
              <p>Reviewer #4: (No Response)</p>
              <p>Reviewer #5: (No Response)</p>
              <p>**********</p>
              <p>2. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
              <p>Reviewer #4: (No Response)</p>
              <p>Reviewer #5: Yes</p>
              <p>**********</p>
              <p>3. Has the statistical analysis been performed appropriately and rigorously? </p>
              <p>Reviewer #4: (No Response)</p>
              <p>Reviewer #5: Yes</p>
              <p>**********</p>
              <p>4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
              <p>Reviewer #4: (No Response)</p>
              <p>Reviewer #5: Yes</p>
              <p>**********</p>
              <p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
              <p>Reviewer #4: (No Response)</p>
              <p>Reviewer #5: Yes</p>
              <p>**********</p>
              <p>6. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
              <p>Reviewer #4: (No Response)</p>
              <p>Reviewer #5: The manuscript is well written and the mathematical model is appreciable. Authors expression of English language too have improved.</p>
              <p>**********</p>
              <p>7. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
              <p>Reviewer #4: <bold>Yes: </bold>Faten Amer</p>
              <p>Reviewer #5: <bold>Yes: </bold>Bamidele Tolulope Odumosu</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
              <supplementary-material id="pone.0252271.s006" position="float" content-type="local-data">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">Reviewer 4.docx</named-content></p>
                </caption>
                <media xlink:href="pone.0252271.s006.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article article-type="author-comment" id="pone.0252271.r008">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r008</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 3</article-title>
              </title-group>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj008" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>4</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">9 May 2021</named-content>
              </p>
              <p>Please, see attached files.</p>
              <supplementary-material id="pone.0252271.s007" position="float" content-type="local-data">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">ResponsetoReferee5.pdf</named-content></p>
                </caption>
                <media xlink:href="pone.0252271.s007.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article article-type="editor-report" id="pone.0252271.r009" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r009</article-id>
              <title-group>
                <article-title>Decision Letter 4</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cheong</surname>
                    <given-names>Siew Ann</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Siew Ann Cheong</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Siew Ann Cheong</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj009" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>4</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">14 May 2021</named-content>
              </p>
              <p>Mathematical modeling of the transmission of SARS-CoV-2 - Evaluating the impact of isolation in São Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of covid-19</p>
              <p>PONE-D-20-19611R4</p>
              <p>Dear Dr. Yang,</p>
              <p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
              <p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
              <p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link xlink:href="http://www.editorialmanager.com/pone/" ext-link-type="uri">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p>
              <p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
              <p>Kind regards,</p>
              <p>Siew Ann Cheong, Ph.D.</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Additional Editor Comments (optional):</p>
              <p>Reviewers' comments:</p>
            </body>
          </sub-article>
          <sub-article article-type="editor-report" id="pone.0252271.r010" specific-use="acceptance-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0252271.r010</article-id>
              <title-group>
                <article-title>Acceptance letter</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cheong</surname>
                    <given-names>Siew Ann</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Siew Ann Cheong</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Siew Ann Cheong</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0252271" id="rel-obj010" related-article-type="reviewed-article"/>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">2 Jun 2021</named-content>
              </p>
              <p>PONE-D-20-19611R4 </p>
              <p>Mathematical modeling of the transmission of SARS-CoV-2 – Evaluating the impact of isolation in São Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of CoViD-19 </p>
              <p>Dear Dr. Yang:</p>
              <p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p>
              <p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p>
              <p>If we can help with anything else, please email us at <email>plosone@plos.org</email>. </p>
              <p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
              <p>Kind regards, </p>
              <p>PLOS ONE Editorial Office Staff</p>
              <p>on behalf of</p>
              <p>Dr. Siew Ann Cheong </p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
            </body>
          </sub-article>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
